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ABSTRACT

Vascular impairments at both the macro- and the micro-circulatory level are known
to be associated with cardiovascular disease (CVD) and may be one of the earlier signs of
disease. As such, it is important to have a means of non-invasively assessing vascular
reactivity, however accurate assessment remains challenging. Tests of flow-mediated
dilation (FMD) have been widely used to non-invasively determine endotheliumdependent vasodilation in humans; however, the use of this technique poses some
challenges. Thus, the purpose of this thesis was to explore new strategies to non-invasively
determine the magnitude and dynamic adjustment of vascular responses in humans. Using
near-infrared spectroscopy (NIRS)-derived measures of tissue oxygen saturation (StO2)
following vascular occlusion it was demonstrated that: 1) the reperfusion rate (Slope 2
StO2) was significantly correlated to the widely used measure of vascular function, FMD
(Chapter II); and 2) that the measure of Slope 2 StO2 had a strong reliability both within
and between testing days (Chapter III). Allometric scaling has been proposed to address
one of the challenges associated with the FMD measurement, however this allometric
scaling, and the development of a new scaling calculation, to account for variability in
baseline diameter between subjects did not improve the measure (Chapter IV).
Additionally, the application of allometric scaling may not be necessary for homogenous
groups. In Chapter V a “dose-response” like curve was constructed for the Slope 2 StO2
measurement across a range of different occlusion durations, to determine differences in
vascular responsiveness, and demonstrated differences in trained versus untrained
individuals. Collectively, these data suggest that the NIRS-derived measure of Slope 2
i

StO2 obtained directly at the microvascular level is reflective of the vascular responsiveness
as measured by FMD. The strong reliability, both intra- and interday, of the NIRS-derived
Slope 2 StO2 measure make this technique suitable for the assessment of vascular
responsiveness, and it is particularly well-suited for determining differences between
groups or before and after an intervention. Slope 2 StO2 is sensitive to different occlusion
durations and changes in this sensitivity of the measure to a variety of ischemic challenges
can be used to detect differences between groups. Therefore, NIRS-derived measures of
StO2 show promise for assessing vascular responsiveness between groups, or for
monitoring changes in vascular responses to various interventions.
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CHAPTER I: Introduction

Importance of Vascular Function
Cardiovascular disease (CVD) is presently the leading cause of morbidity and
mortality (Lloyd-Jones et al., 2010; Green et al., 2011) and although most traditional risk
factors (i.e., high blood lipids, hypertension, diabetes, etc.; Mora et al. 2007, Green et al.
2008) are not detected until later in life, changes in macro- and micro-vascular functions,
which have been proposed as predecessors of CVD, have been shown to be present as early
as adolescence (Celermajer et al., 1992; Khan et al., 2003). It has been well established
that exercise decreases cardiovascular risk, and that the risk reduction is greater than would
be expected based on the reductions observed in traditional risk factors (Mora et al., 2007).
Vascular impairments at both the macro- and the micro-circulatory level are known to be
associated with CVD (Lloyd-Jones et al., 2010; Seals, 2014), and it is proposed that direct
effects on the vessel wall may account for some of the exercise-related risk reduction
independently of the factors listed above (Green et al., 2008).
More specifically, endothelial dysfunction, commonly expressed as deficiencies in
nitric oxide (NO) production and release by the endothelial cells, and the consequent
reduction in vascular responsiveness has been proposed to play a pivotal role in the
advancement of CVD (Langham & Wehrli, 2011), independent of changes in smooth
muscle function. Studies in CVD patients with more severe disease have shown that
changes in smooth muscle function do occur and have suggested that these changes occur
subsequent to changes in the endothelium (Maiorana et al., 2003; Green et al., 2004;
Thijssen et al., 2010; Seals, 2014). This has led to a proposed “hierarchy of dysfunction”,
insinuating that impairments in vascular function begins with the endothelium and can
1

migrate to the rest of the vessel wall with disease progression (Green et al., 2011). In this
context, non-invasive assessment of endothelium-dependent vascular responses becomes
an important instrument for early detection of pre-clinical dysfunction, diagnosis,
monitoring of treatment and possibly even prevention of CVD.

Structure of the Vasculature
Blood flows through the peripheral vasculature via a closed network circuit of
conduit arteries and arterioles, ultimately terminating at the capillaries before entering the
venous circulation. The conduit arteries, are elastic vessels and the smooth muscles of the
arterial walls of these arteries contract or relax to regulate the flow of blood through their
lumen. Blood flow through the vessel is governed by Poiseuille’s law;
𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤 =

∆𝑃𝜋𝑟 4

(1.1)

8ɳɭ

Where ΔP is the pressure gradient across the vessel, r is the vessel radius, ɳ is the viscosity
of the blood and ɭ is the vessel length. As blood flow is related to r raised to the fourth
power, small changes in vascular diameter have substantial effects on flow. In this way,
the arterioles can control how much blood flows to different parts of the body under various
cardiovascular challenges (i.e., ischemia, exercise, etc.).
Arteries are composed of several cell types that are integral to this regulation of
vascular tone. The outer adventitial layer (tunica externa) consists of perivascular nerves
and the extracellular matrix. The middle layer (tunica media) contains the vascular smooth
muscle cells, which are oriented perpendicular to the lumen of the vessel to provide
circumferential force allowing for changes in lumen diameter. The innermost layer (tunica
intima) consists of the internal elastic lamina and endothelium. The internal elastic lamina
2

separates the smooth muscle layer from the endothelium. The innermost layer of the blood
vessel is composed of a single layer of endothelial cells oriented longitudinally to sense
shear forces associated with blood flow through the lumen.
Function of the Endothelium
The endothelium is a single layer of cells lining all the blood vessels in the body.
In the case of the smallest blood vessels, the capillaries, endothelial cells constitute the
entire wall structure. It controls many important functions including maintenance of blood
circulation and fluidity as well as regulation of vascular tone, coagulation and
inflammatory responses. The endothelium responds to flow and shear stress which initiates
a cascade of events that leads to the production of nitric oxide (NO) and resultant
vasodilation.

This flow-mediated, endothelium dependent mechanism has been

extensively researched and is the principle that supports a method to non-invasively assess
endothelial function/ dysfunction commonly termed flow-mediated dilation (FMD).
Vascular Anatomy of the Leg
Figure 1.2 illustrates the major arteries of the lower limb. Blood flows through the
femoral artery into the popliteal artery, the major conduit responsible for the perfusion of
the lower leg. The popliteal artery descends down the posterior thigh, giving off genicular
branches that supply the knee joint. The popliteal artery moves through the popliteal fossa
and terminates by dividing into the anterior and posterior tibial arteries.
The posterior tibial artery continues inferiorly (through the back of the leg), along
the surface of deep muscles (i.e., flexor muscles) and ultimately enters the sole of the foot.
It also gives rise to the peroneal artery which supplies the lateral peroneal muscles of the
leg. The other division of the popliteal artery, the anterior tibial artery, passes between the
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tibia and fibula and runs through the anterior compartment of the leg. It runs down through
the entire length of the leg and into the foot, supplying the extensor muscles along the way
(including the tibialis anterior muscle).

4

Figure 1.1. Major arteries of the lower leg; anterior view of the left leg.
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Flow-mediated Dilation
The reactive hyperemia endothelial function test, commonly referred to as an FMD
test was first proposed in 1992 (Celermajer et al., 1992) and involves Doppler ultrasound
imaging of conduit artery responses to shear stress-induced FMD, consequent to a brief
period of ischemia. This technique generates a shear stress stimulus, resulting in a dilation
of downstream resistance vessels following the occlusion of blood flow to the limb with a
pressure cuff. Upon cessation of the occlusion, inflow of blood through the conduit artery
is transiently increased (reactive hyperemia) and acts as the stimulus for FMD.
In humans FMD is typically assessed in the large peripheral conduit arteries and is
considered representative of the response in the more clinically relevant coronary
circulation (Takase et al. 1998). As a result of the close relationship to the coronary
circulation, the FMD test has become widely used as a measure of endothelial dysfunction
in both clinical and asymptomatic patients. Experimental and clinical studies suggest that
endothelial dysfunction is an important feature of vascular disease and is strongly
associated with several cardiovascular conditions, including atherosclerosis (Ross, 1999),
hypertension (Taddei et al., 1993; Perticone et al., 2001; Modena et al., 2002), and
coronary and peripheral artery disease (Yataco et al., 1999; Zhang et al., 2000; Neunteufl
et al., 2000; Kuvin et al., 2001; Brevetti et al., 2003), and that endothelial dysfunction can
predict cardiovascular events in these groups (Gokce et al., 2002; Widlansky et al., 2003).
Animal studies established that FMD in arteries was dependent on the presence of
an intact endothelial lining (Smiesko et al., 1985; Pohl et al., 1986) and that in response to
shear stress, the endothelium releases a substance now known as NO (Rubanyi et al., 1986;
Moncada et al., 1988). Therefore, reductions in FMD are widely assumed to reflect
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diminished NO production as several pivotal human studies have concluded that FMD is,
at least in part, dependent on an NO pathway (Joannides et al., 1995; Mullen et al., 2001;
Doshi et al., 2001; Jiang et al., 2011). Studies involving the administration of NO
blockade, such as NG-monomethyl-L-arginine (L-NMMA), have confirmed the major role
that NO plays in the regulation of vascular tone. Joannides et al. (Joannides et al., 1995)
found that radial artery dilation following 3 minutes of ischemia was abolished in the
presence of L-NMMA. Similarly, Mullen et al. (Mullen et al., 2001) found that NO
blockade decreased the radial artery FMD response to 5 minutes of ischemia from 5.3% to
0.7% dilation, with no difference in hyperemic stimulus, concluding that it was unlikely
that stimulus magnitude was responsible for the abolished FMD response.
Figure 1.3 details the pathway of endothelial-dependent vasodilation in response to
increases in blood flow, or fluid shear stress. Immediately following cuff release, the
resultant increase in blood flow creates a shear stress stimulus causing deformation of
mechanosensitive structures on the endothelial cell membrane, such as membrane proteins
(glycocalyx), primary cilia and mechanosensitive ion channels (Pyke & Tschakovsky,
2005; Davies, 2009). The acute response to the shear stress stimulus is the opening of
calcium (Ca++)-activated potassium channels, causing hyperpolarization of the endothelial
cell (Olesen et al., 1988; Cooke et al., 1991; Miura et al., 2001). This results in an increased
driving force for Ca++ entry into the cell. The increased [Ca++] triggers phosphorylation of
endothelial nitric oxide synthase (eNOS) which in turn increases the conversion of Larginine to L-citrulline and produces NO (Pohl et al., 1986; Joannides et al., 1995). Over
prolonged periods of shear stress stimulus, the mechanosensitive structures signal increases
G-protein expression and resultant phosphorylation of eNOS (Corson et al., 1996;
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Dimmeler et al., 1999). This increase in eNOS activity increases the production of NO,
even at low concentrations of calcium. Vasodilators diffuse from the endothelial cell into
the tunica media (composed of smooth muscle), which in the case of NO activates the
enzyme guanylate cyclase. This increases the conversion of guanosine triphosphate (GTP)
to cyclic guanosine monophosphate (cGMP), which acts to decrease the concentration of
intracellular [Ca++] and induces relaxation of the smooth muscle and subsequent
vasodilation.
As mentioned previously, there is some redundancy in the mechanisms controlling
vasodilation. In addition to multiple mechanosensitive structures on the endothelial cell
surface, there are also multiple vasodilatory pathways within the endothelial cell which
may contribute to FMD (Sun et al., 1999; Mullen et al., 2001; Doshi et al., 2001; Pyke et
al., 2009; Parker et al., 2011). Studies have shown that in the absence of NO there are
other pathways that can be upregulated to ensure continued functioning, at least in part, of
the endothelium.

For example, a study using blood vessels from mice, genetically

engineered to lack eNOS, found they still responded to shear stress by dilating (Sun et al.,
1999). Other animal models have determined prostaglandins (PGs) and endothelialderived hyperpolarizing factor (EDHF) may also contribute to endothelial-dependent
vasorelaxation (Huang et al., 1998; Pak et al., 2002; Scotland et al., 2005). More recently,
Pyke et al. (Pyke et al., 2009) were unable to reduce radial artery FMD with a large dose
of L-NMMA and concluded that there may be heterogeneous vasodilator phenotypes which
affect the contribution of NO to FMD. Although other vasodilators can be released by the
endothelium, reviews in the area have demonstrated that FMD of conduit arteries in
humans is, at least in part, mediated by NO (for meta-analysis see Green et al. 2014).
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Figure 1.2. Schematic representation of the pathways involved in flow-mediated dilation
(FMD) from the initial fluid shear stress stimulus to the resultant change in vessel
diameter. Adapted from McLay, 2012.
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Changes in FMD with Interventions
FMD is presently the most widely used non-invasive method to assess endothelial
function and has been used to detect changes in responsiveness of the vasculature following
various interventions. The majority of studies undertaken in subjects with CVD or risk
factors report that exercise training interventions improve vasodilator function of resistance
and conduit arteries (Thijssen et al., 2010). For example, Maiorana et al. (Maiorana et al.,
2001a) reported an increased FMD response in the brachial artery following eight weeks
of a combined aerobic and resistance training program in patients with type 2 diabetes.
Additionally, they reported improved forearm blood flow following acetylcholine (ACh)
infusion, indicative of enhanced endothelial-dependent vasodilation of the resistance
vessels as well. Similarly, coronary artery disease (CAD) patients, who had lower brachial
FMD responses compared to healthy controls, showed an improved conduit vasodilatory
response with eight weeks of exercise training (Walsh et al., 2003). Following training,
the reported FMD responses in the CAD patients were similar to those reported for the
healthy controls.
Studies examining the influence of exercise training in healthy populations have
reported more inconsistent findings, however, these inconsistencies appear to be a result of
the various training stimuli. Studies that reported improvements in FMD following training
interventions suggest that a moderate to higher intensity endurance-type exercise may be
required to improve endothelial function in these healthy individuals (Green et al., 2004;
Birk et al., 2013). It has also been suggested, it has been reported that improvements in
vascular function with exercise training can occur rapidly (Tinken et al., 2008), and may
then be succeeded by adaptations in arterial structure.

10

Limitations with FMD Assessment of Vascular Function
The FMD test offers a non-invasive measure of conduit artery function, which can
provide valuable prognostic information; however this technique is not without limitation.
First, the use of Doppler ultrasound for the determination of FMD requires costly
equipment and skilled personnel for reliable data acquisition. Secondly, although FMD
provides insight into peripheral conduit artery vasoreactivity in response to the shear stress
stimuli, this measure largely negates other signaling pathways and vasodilator mechanisms
that may also contribute to the response. In addition, there is no assessment of downstream
hyperemia within the tissue itself. Finally, the results from the FMD test primarily focus
on the changes in conduit artery dilation from a baseline to a post-occlusion value
expressed as a percent dilation. Not only have concerns about the statistical bias of this
calculation been recently broached (Atkinson et al., 2013), but this commonly reported
value also neglects the dynamic adjustments of the response.
As outlined previously, changes in vascular function with interventions such as
exercise training may follow a relatively rapid time-course that is succeeded by structural
adaptations. For example, Tinken et al. (Tinken et al., 2008) reported functional changes
(i.e., improved FMD) two weeks into an eight week exercise training intervention. These
improvements in FMD were sustained at four weeks, however returned toward pre-training
values with six to eight weeks of training. In this case, it is not that individuals exhibit
endothelial dysfunction as the training program progressed, but that the structural
adaptations that occur impede the ability of FMD to accurately assess vascular function.
Therefore, this measure may not be ideally suited for detecting differences across exercise
training interventions.

11

Near-infrared Spectroscopy
Near-infrared spectroscopy (NIRS) is a non-invasive optical method used for
measuring tissue oxygenation. Measurements are based primarily on the absorption of
light at wavelengths in the NIR range (700-900 nm), because oxygenated hemoglobin
(HbO2) and deoxygenated hemoglobin (HHb) display different light absorption
characteristics. Specifically, NIR light is transmitted from an emitting diode to a lightdetecting optode after passage through tissue, where the penetration depth is approximately
half the distance of the inter-optode spacing (Kalliokoski et al., 2006). Because HbO2 and
HHb display these different light absorption characteristics, by emitting light at several
specific wavelengths in the NIR range of the spectrum and detecting changes in these
received signals (i.e., after passing through tissue), precise separation and quantification of
changes in these compounds is made possible. The changes in HbO2 and HHb can be
measured continuously, and tissue oxygen saturation (StO2) can be extrapolated (defined
as [HbO2] / [HbO2 + HHb]) (Ferrari et al., 2004).
The microcirculation can be isolated because the light emitted into the larger vessels
(arteries and veins) is almost completely absorbed by the larger relative molar
concentration of hemoglobin (Hb), and thus any detectable changes in absorption can be
attributed to the microcirculation. One limitation of the NIRS technique is the overlapping
absorption spectra of muscle myoglobin (Mb) and Hb; this makes separation of these
absorbers difficult. However, the contribution of Mb to light absorption changes is
estimated to be ~10%, which leads to the interpretation that light absorption changes with
NIRS are attributable mainly to the oxygenation status of Hb (Kalliokoski et al., 2006).
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By precisely separating and quantifying changes in [HbO2] and [HHb], NIRS has
been used to provide an index of O2 extraction during exercise in humans and has become
widely used to obtain measures of tissue oxygenation and hemodynamics at rest and during
different exercise modalities and intensities (McCully et al., 1994; De Roia et al., 2012;
Murias et al., 2012; Bellotti et al., 2013). More recently, it has been reported that static
and dynamic measures of StO2 during a vascular occlusion test (VOT) can help in
evaluating peripheral perfusion in some clinical settings (Kragelj et al., 2001; Doerschug
et al., 2007; Creteur et al., 2007a; Mayeur et al., 2011; Lipcsey et al., 2012; De Backer et
al., 2013); specific studies in which NIRS was used in this way are discussed below.
StO2 Measurements in Clinical Populations
NIRS is by no means a new technology, however advancements relating to the
technology have led to the increasing use, especially within clinical populations. Early
measures of StO2, to evaluate peripheral perfusion, suggested that regional oxygenation
measured by NIRS was able to non-invasively detect progressive hypovolemia. In trauma
patients, suffering from this condition of low blood volume, absolute values of StO2 were
demonstrated to have a strong prognostic value such that low StO2 values during initial
exams were associated with larger transfusion requirements (Moore et al., 2008; Smith et
al., 2008; Beekley et al., 2010), increased risk of infection (Ikossi et al., 2006), organ
failure (Ikossi et al., 2006; Cohn et al., 2007) and higher mortality rates (Cohn et al., 2007).
The research surrounding the measurement of absolute StO2 values in trauma patients
indicated that NIRS provided valuable prognostic information, however, in septic
conditions this association was less clear (Leone et al., 2009; Shapiro et al., 2011). Patients
with septic shock exhibit diverse microcirculatory effects, such that the same vascular bed
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can have ischemic and highly oxygenated regions ultimately leading to “normal”
oxygenation measures of that area. Patients with this condition appear to have lower StO2
values compared to healthy controls however there was a vast overlap between the two
groups (Lipcsey et al., 2012). These observations lead to a shift in focus away from
measurements of absolute StO2 values and lead to exploration of the dynamic StO2
parameters derived from a vascular occlusion test (VOT).
Vascular Occlusion Test
The VOT consists of an arterial occlusion, similar to that of the FMD test, however
occlusion occurs proximal to the NIRS probe site. The StO2 response is measured
throughout the duration of the test (before, during and after the ischemic challenge) and
provides dynamic information which has been used to evaluate peripheral perfusion in
some clinical settings (Kragelj et al., 2001; Doerschug et al., 2007; Creteur et al., 2007a;
Mayeur et al., 2011; Lipcsey et al., 2012; De Backer et al., 2013). Figure 1.4 depicts the
StO2 response to a VOT.
A parameter of particular interest is the reperfusion slope, or the rate of re-saturation
immediately following cuff release. This slope likely reflects the vascular reactivity of the
microvasculature throughout the 5 minute vascular occlusion. While the FMD response to
ischemia (macrovascular reactivity) is largely attributed to a single dilatory pathway
(Green et al., 2014), the mechanisms governing the control of microvascular blood flow
distribution are not fully understood. There are likely multiple mechanisms influencing
the microvascular response, one of which is shared with the FMD measure (i.e.,
endothelial-dependent nitric oxide-mediated vasodilation). The endothelium is likely to
play a major role both detecting oxygen concentration in the capillary and by inducing
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vasodilation by releasing NO (Greenberg & Kishiyama, 1993). However, additional
pathways that may be influencing the StO2 reperfusion slope may include metabolic
pathways and even red blood cells themselves have been identified as regulators of oxygen
delivery and distribution rather than just transporters (Bergfeld & Forrester, 1992). That
being said, no study has compared the reperfusion slope with that of the widely used FMD
assessment of endothelial function.
As mentioned previously, several studies have examined the dynamic adjustment
of StO2 response in combination with the VOT in clinical settings (For complete reviews
see Mesquida et al. 2013, Boezeman et al. 2016).

For example, Doerschug et al.

(Doerschug et al., 2007) reported the reperfusion rate during the hyperemic response of the
thenar eminence muscle was significantly slower in septic subjects than in controls and this
impairment was accentuated in those with more severe organ failure. Similarly, Creteur et
al. (Creteur et al., 2007a) found that the reperfusion slope was steeper in patients with
severe sepsis who survived than in non-survivors. Additionally, they reported that the
reperfusion slope tended to increase in survivors across the 48 h observation period but not
in non-survivors. Taken together, these studies suggest that NIRS-derived measures of
StO2, specifically the reperfusion slope, can monitor differences in vascular
responsiveness.
Very few studies to date have explored the use of the NIRS-derived StO2 response
to a VOT in healthy populations, and each of these studies have related to methodological
approaches to the technique such as probe spacing (Bezemer et al., 2009), comparing
measurement sites (Bezemer et al., 2009; Fellahi et al., 2014) and modelling of the
reperfusion response (Bopp et al., 2011). The sensitivity of the measurement has been
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clearly established in clinical populations to detect differences in vascular responsiveness
compared with controls. However, it remains unclear whether the more subtle differences
expected in vascular function between two healthy populations (i.e., trained and untrained)
can be detected.
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Figure 1.3. The NIRS-derived profile of % tissue oxygen saturation (StO 2) throughout a
vascular occlusion test. BSLN StO2 (%), baseline StO2 prior to ischemia; Slope 1 StO2
(%/s), StO2 downslope following cuff inflation is considered to reflect muscle metabolism;
Min StO2 (%), absolute value for lowest StO2 value reached during ischemia; Slope 2 StO2
(%/s), StO2 reperfusion slope following cuff release and is considered to be dependent on
the accumulation of metabolites during the ischemic phase; Peak StO2 (%), highest
absolute StO2 value reached following cuff release. Adapted from McLay et al., 2016.
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Summary, Overall Purpose of the Thesis
Vascular impairments at both the macro- and the micro-circulatory level are known
to be associated with CVD and may be one of the earlier signs of disease. Using In vivo
animal models, direct determination of endothelium-mediated vascular responsiveness is
possible even at different levels of vascular organization (Muller-Delp, 2006; Murias et al.,
2013). However, accurate assessments of vascular reactivity are more challenging in
humans. Tests of FMD have been widely used to non-invasively determine endotheliumdependent vasodilation in humans, and they are well documented to detect differences in
vascular responsiveness in different groups such as trained versus untrained individuals
(Allen et al., 2003; Green et al., 2003, 2010; Rakobowchuk et al., 2008; Black et al., 2009;
Thijssen et al., 2011b; Currie et al., 2012; Birk et al., 2013). However, the use of this
technique poses some challenges. Thus, the overall purpose of this thesis is to explore new
strategies to non-invasively determine the magnitude and dynamic adjustment of vascular
responses in humans.

Overview of Studies
Chapter II will compare the more recently developed NIRS-derived measure of
vascular function to that of the widely used ultrasound-derived flow-mediated dilation
technique. The subsequent studies that comprise this thesis will build on the development
and application of this technique as a reliable measure sensitive to differences in vascular
responsiveness, and address some of the challenges with the FMD technique. The specific
purposes of this thesis were:
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1. To evaluate if NIRS technology can be used as a measure of vascular
responsiveness by establishing a correlation between the NIRS-derived StO2
reperfusion slope and the ultrasound-derived measure of flow-mediated dilation.
2. To examine the test-to-test reliability (variability between repeated tests within a
single day) and day-to-day reliability of the NIRS-derived measure Slope 2 StO2,
and compare it to the widely used measurement of flow-mediated dilation.
3. To examine if the employment of a new approach to allometrically scale values for
flow-mediated dilation can improve the ability to obtain individual values that are
corrected for variations in baseline diameter between subjects.
4. To determine if the NIRS-derived measure of StO2 reperfusion slope (Slope 2
StO2), which reflects vascular responsiveness, is sensitive to a range of ischemic
conditions (i.e., various occlusion durations) and to determine if differences exist
between two groups that would be expected to have different vascular
responsiveness (i.e., trained and untrained individuals).
Hypotheses
This thesis specifically addressed the following hypotheses:
1. There would be a significant correlation between the ultrasound-derived measured
of vascular responsiveness (FMD) and NIRS-derived reperfusion rate (Slope 2
StO2).
2. That the reliability of the NIRS-derived measure for the reperfusion rate (Slope 2
StO2) would be better than that of flow-mediated dilation for three tests repeated in
a single day and five tests performed across five separate days.
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3. Individual FMD values obtained from the new allometrically scaled calculation for
flow mediated dilation would more closely resemble those typically presented for
FMD calculated in the traditional manner, while still obtaining the benefits of
controlling for variations in baseline diameter.
4. The reperfusion rate (Slope 2 StO2) would progressively increase with the increase
in occlusion duration and there will be differences in the reperfusion rate of trained
and untrained individuals, such that trained individuals would have a steeper Slope
2.
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CHAPTER II: Vascular responsiveness determined by near-infrared spectroscopy
measures of oxygen saturation

Introduction
Cardiovascular disease (CVD) is presently the leading cause of morbidity and
mortality (Lloyd-Jones et al., 2010; Green et al., 2011). Vascular impairments at both the
macro- and the micro-circulatory level are known to be associated with CVD (Lloyd-Jones
et al., 2010). More specifically, deficiencies in nitric oxide (NO) production and release
by the endothelial cells, and the consequent reduction in vascular responsiveness have been
proposed to play a pivotal role in the advancement of CVD (Langham & Wehrli, 2011).
As such, proper assessment of endothelium-dependent vascular responses becomes an
important instrument for early detection of pre-clinical dysfunction, diagnosis, monitoring
of treatment efficacy and possibly prevention of CVD.
Using animal models, direct determination of endothelium-mediated vascular
responsiveness is possible even at different levels of vascular organization (Muller-Delp,
2006; Murias et al., 2013). However, accurate assessments of vascular reactivity are more
challenging in humans. Tests of flow-mediated dilation (FMD) have been widely used to
determine endothelium-dependent vasodilation in humans as they are considered the “gold
standard” for non-invasively measuring this response; FMD is well documented to detect
differences in vascular responsiveness in different groups such as trained versus untrained
(Allen et al., 2003; Green et al., 2003, 2010; Rakobowchuk et al., 2008; Black et al., 2009;
Thijssen et al., 2011b; Currie et al., 2012; Birk et al., 2013) or older versus young (Parker
et al., 2006; Black et al., 2009; Green et al., 2010) individuals. However, the use of this
technique poses some challenges. The use of Doppler ultrasound for the determination of
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FMD requires high cost equipment and skilled personnel for data acquisition. In addition
to this, although FMD provides insight into peripheral conduit artery vasoreactivity, there
is no assessment of downstream hyperemia within the tissue itself. Moreover, the results
from the FMD test primarily focus on the changes in conduit artery dilation from a baseline
to a post-occlusion value expressed as a percent dilation, which neglects the dynamic
adjustments of the response. Thus, exploring new strategies to non-invasively determine
the magnitude and dynamic adjustment of vascular responses in humans is warranted.
A recent study has examined different dynamic parameter estimates of oxygenated
hemoglobin (HbO2) and blood flow velocity following cuff occlusion of the femoral artery
using multi-echo gradient-recalled sequence (Langham & Wehrli, 2011). Although this
novel approach considered the dynamic effect of the post-occlusion hyperemic responses,
the methodology used in the study makes data collection and analysis difficult to
incorporate into a clinical setting. Within the last decade, near-infrared spectroscopy
(NIRS) has become widely used to obtain measures of tissue oxygenation and
hemodynamics at rest and during different exercise modalities and intensities (McCully et
al., 1994; De Roia et al., 2012; Murias et al., 2012; Bellotti et al., 2013). More specifically,
it has been recently reported that static and dynamic measures of StO2 during a vascular
occlusion test (VOT) can help in evaluating peripheral perfusion in some clinical settings
(Kragelj et al., 2001; Doerschug et al., 2007; Creteur et al., 2007a; Mayeur et al., 2011;
Lipcsey et al., 2012; De Backer et al., 2013). The VOT is commonly performed on the
thenar eminence (Doerschug et al., 2007; Gómez et al., 2008; Bezemer et al., 2009; Mayeur
et al., 2011; Bopp et al., 2011; Lipcsey et al., 2012) with very few studies applying this
technique on other sites (Kragelj et al., 2001; Fellahi et al., 2014). Although the thenar
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eminence is useful for bed-side measures with intensive care patients, exploring different
measurement sites of StO2 may provide more insight into the relationship between macroand micro-circulatory responses to occlusion for a region that may be more sensitive to
evaluate the effect of interventions (i.e., acute and chronic exercise interventions) on
vascular reactivity.
Therefore, the purpose of the present study was to evaluate if NIRS can be used as
a measure of vascular responsiveness by establishing a correlation between the NIRSderived StO2 reperfusion slope and FMD. Based on the expected relationship between
macrovascular responsiveness (FMD) and reperfusion rate (Slope 2 StO2), we
hypothesized that these two variables would be significantly correlated.
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Methods
Participants
20 healthy young (age, 26 ± 3 yr; height, 177 ± 7 cm; weight, 82 ± 10 kg; VO2max,
46 ± 5 ml∙kg-1∙min-1) adult men volunteered and gave written consent to participate in the
study. This was a multi-site project with subjects being recruited and tested in London,
Ontario, Canada and in Verona, Italy. All procedures conformed to the standards set by
the latest revision of the Declaration of Helsinki and were approved by The University of
Western Ontario Research Ethics Board for Health Sciences Research Involving Human
Subjects and the Ethical Committee of the Department of Neurological and Movement
Sciences, University of Verona (REB file number 102273).

All participants were

recreationally active and non-smokers. Additionally, all subjects were normotensive
(Systolic: 125 ± 9; Diastolic: 72 ± 9) and no subjects were taking medications that would
affect hemodynamic responses.
Protocol
Two FMD tests were performed on each participant, each separated by a 30 minute
rest period to allow blood flow and arterial dilation to return to resting conditions (Harris
et al., 2006). Resting blood pressure was measured in triplicate prior to each FMD test,
and was taken as the average of the three measurements.
Popliteal artery assessments
FMD of the popliteal artery was assessed in accordance with previously published
guidelines for the current standardized methodology (Corretti et al., 2002; Thijssen et al.,
2011a). All participants were instructed to refrain from caffeine, alcohol and exercise for
12 hours prior to their scheduled visit. Following at least 10 minutes of supine rest,
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participants were instructed to lie prone as ultrasound imaging was performed on the back
of the knee. A small pillow was placed under the participant’s ankle for comfort and
optimization of the knee angle so there was no leg movement throughout the cycles of the
FMD tests. The left popliteal artery was imaged immediately proximal to the bifurcation
(usually at or slightly above the popliteal fossa), and a pneumatic cuff (Flexiport; Welch
Allyn Inc., Skaneateles Falls, NY, USA) was placed around the calf (approximately 5 cm
distal to the popliteal fossa). Heart rate was continuously monitored with a three-lead ECG
to allow for consistent and accurate selection of arterial diameter measurements at the end
of the diastolic phase of the cardiac cycle.
The popliteal artery was imaged with a 10-MHz multifrequency linear-array
transducer attached to a Doppler ultrasound machine (VingMed System FiVe, GE Medical
Systems, Horten, Norway). All scans were performed by an experienced investigator. All
scans were made with similar ultrasound settings and all images were recorded on an
external video camera (HDD Everio; JVC, Canada) for later offline analysis. Baseline
diameter was recorded prior to manual inflation of the pneumatic cuff. The cuff was then
inflated for 5 minutes to an occlusion pressure of 250 mmHg, during which diameter was
not recorded. Fifteen seconds prior to release of the cuff the video camera resumed
recording and at exactly 5 minutes after inflation, the pneumatic cuff was released and
arterial diameter was continuously monitored for 5 minutes post-release.
Diameter measurements, defined as the distance between the media and intima
interface of the near wall and far wall, were obtained using a caliper that converted image
pixels to millimeters. Triplicate measurements of diameter were taken for each of five
baseline images and averaged to determine the baseline diameter (Dbase) of the artery.
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Similarly, triplicate measurements of diameter were averaged for images taken every 15
seconds following cuff release. Peak diameter (Dpeak) was determined as the post-occlusion
image with the largest diameter and percent flow-mediated dilation (%FMD) was then
calculated as the percent change in diameter from Dbase.
Near-infrared spectroscopy.
StO2 of the tibialis anterior muscle was monitored continuously with a frequencydomain multi-distance near-infrared spectroscopy (NIRS) system (Oxiplex TS, ISS,
Champaign, Ill., USA). Briefly, the system was composed of a single channel consisting
of 8 laser diodes operating at 2 wavelengths (λ = 690 and 828 nm, 4 at each wavelength),
which were pulsed in rapid succession, and a photomultiplier tube. The lightweight plastic
NIRS probe (connected to laser diodes and a photomultiplier tube by optical fibers)
consisted of 2 parallel rows of light emitter fibers and 1 detector fiber bundle; the sourcedetector separations for this probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. The
probe was placed on the belly of the muscle, was secured in place with an elastic strap
tightened to prevent movement and was covered with an optically dense, black vinyl sheet,
thus minimizing the intrusion of extraneous light. An elastic bandage was applied to
further minimize intrusion of extraneous light and probe movement. By measuring
changes in light absorption at different wavelengths, changes in oxyhemoglobin (HbO2)
and deoxyhemoglobin (HHb) can be measured continuously, and StO2 can be extrapolated
(defined as [HbO2] / [HbO2 + HHb]). NIRS measurements were collected continuously
for the entire duration of each FMD test (2 min baseline, 5 min occlusion and 5 min postrelease) plus an additional 3 minutes following cuff release (for a total of 8 minutes postrelease).
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The NIRS device was calibrated at the beginning of the first test session following
an instrument warm-up period of at least 20 min. The calibration was done with the probe
placed on a calibration block (phantom) with absorption (μa) and reduced scattering
coefficients (μs’) previously measured; thus, correction factors were determined and were
automatically implemented by the manufacturer’s software for the calculation of the μa and
μs’ for each wavelength during the data collection. Calculation of [HbO2] and [HHb]
reflected continuous measurements of μs’ made throughout each testing session (i.e.,
constant scattering value not assumed). The probe remained secured to the leg throughout
the duration of the visit to ensure measurement consistency between both FMD tests. Data
were stored online at an output frequency of 2 Hz, but were reduced to 1 s bins for all
subsequent analyses within the present study.
The NIRS parameters calculated are depicted in Figure 2.1. Baseline StO2 (BSLN
StO2, %) was calculated as the average StO2 prior to ischemia. The desaturation rate was
quantified as the downslope of StO2 (Slope 1 StO2, %/S) measured from 30 to 150 seconds
following cuff inflation. Minimum StO2 (%) was calculated as the lowest StO2 value
attained during ischemia. The StO2 reperfusion rate was quantified as the upslope of a 10
second window following cuff release of the StO2 signal (Slope 2 StO2, %/s). Peak StO2
(%) was calculated as the highest StO2 value reached following cuff release.
Statistical Analysis
All data were imported into SigmaPlot 11 (Systat Software, Inc., SanJose, CA,
USA).

Correlation coefficients (Pearson product moment) were used to determine

relationships of FMD and NIRS-derived Slope 2 StO2, as well as the relationships between
NIRS-derived parameters. Statistical significance was declared when p < 0.05. All data
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are presented as means ± standard deviation. The coefficients of variation (CV) were
calculated for %FMD and the NIRS-derived Slope 2 StO2.
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Results
FMD: Group means and standard deviation for baseline diameter, peak diameter and
%FMD are reported in Table 2.1.
NIRS: Group means and standard deviation for StO2 parameters are listed in Table 2.1.
%FMD was significantly correlated with Slope 2 StO2 (R = 0.63, df = 19, p = 0.003; Figure
2.2). There was no significant correlation between Slope 2 StO2 and the minimum StO2
(R = 0.34, df = 19, p = 0.15) or between Slope 2 StO2 and Slope 1 StO2 (R = 0.35, df = 19,
p = 0.13).
The CVs for %FMD and Slope 2 StO2 were 29.3 ± 13.3% and 11.0 ± 7.8%,
respectively.
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Table 2.1. Ultrasound- and NIRS-derived measurements throughout a vascular occlusion
test.

Young Men
(n = 20)
Ultrasound-derived Measures
Baseline diameter (mm)
Peak diameter (mm)
Flow-mediated dilation (%)
NIRS-derived Measures
Baseline StO2 (%)
Minimum StO2 (%)
Slope 1 StO2 (%∙s-1)
Peak StO2 (%)
Slope 2 StO2 (%∙s-1)
Notes: Values are means ± standard deviations.

38

6.7 ± 0.5
7.1 ± 0.6
6.7 ± 3.4
71.3 ± 2.9
44.8 ± 8.6
-0.10 ± 0.03
82.6 ± 2.3
1.63 ± 0.5

Figure 2.1. NIRS-derived profile of % tissue oxygen saturation (StO2) for a representative
subject measured during a vascular occlusion test.
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Figure 2.2. Individual values of flow-mediated dilation, expressed as percentage of the
baseline diameter value (%FMD), are plotted as a function of the speed of re-oxygenation
(Slope 2 StO2) after cuff release during the vascular occlusion test in young adults.
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Discussion
The main goal of this study was to determine if a relationship existed between
NIRS-derived StO2 reperfusion slope (microvascular response) and FMD (arterial vascular
responsiveness) measured in healthy young adult men. The main finding was that the
NIRS-derived measure of tissue O2 saturation, Slope 2 StO2, was significantly associated
with the FMD response, such that the Slope 2 StO2 provides a measure of vascular
reactivity.
During a vascular occlusion test the reperfusion phase following cuff release,
results in an immediate increase in blood flow to the ischemic limb, characterized by Slope
2 StO2. The present study is the first known to the authors to establish a correlation between
the “gold-standard” technique for non-invasive assessment of vascular function and the
more recently proposed NIRS technique for assessing vascular responsiveness. Slope 2
StO2 was significantly correlated with %FMD likely related to the fact that both FMD and
Slope 2 StO2 are, at least in part, dependent upon the increase in metabolism as a result of
ischemia. Although FMD by definition is the dilatory response to an increase in flow,
downstream accumulation of catabolites during the ischemic period results in a rapid
dilation of smaller vessels (ie. 3A and terminal arterioles) (Berg et al., 1997). This
downstream dilation (i.e. the drop in local resistance) elicits the resultant hyperemic
response that stimulates the FMD in the upstream conduit artery. Thus, this significant
correlation between %FMD and Slope 2 StO2 is important from a physiological
perspective.
The present study is the first to our knowledge to utilize NIRS during vascular
occlusion in healthy young adults and attempt to associate the reperfusion slope of the StO2
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with endothelial function. However, this technique has been previously used in clinical
populations (i.e., patients with sepsis and septic shock) to assess peripheral perfusion
(Kragelj et al., 2001; Doerschug et al., 2007; Creteur et al., 2007a; Mayeur et al., 2011;
Lipcsey et al., 2012; De Backer et al., 2013). For example, Doerschug et al. (Doerschug
et al., 2007) reported the reperfusion rate during the hyperemic response of the thenar
eminence muscle was significantly slower in septic subjects than in controls and this
impairment was accentuated in those with more severe organ failure. Similarly, Creteur et
al. (Creteur et al., 2007a) found that Slope 2 StO2 was higher in patients with severe sepsis
who survived than in non-survivors. Additionally, they reported that Slope 2 StO2 tended
to increase in survivors over the observation period but not in non-survivors. These studies
utilized patients with severe sepsis, an inflammatory response that can alter blood flow
distribution, and suggested that NIRS-derived measures of StO2, specifically the
reperfusion slope, could monitor differences in hemodynamic responses, which aligns with
results from the present study.
An important aspect of the present study is the strong and significant correlation
that was reported between Slope 2 StO2 and %FMD, in spite of the high variability for
FMD. The %FMD measure has been shown to have low reliability, which is associated
with a large error (Hijmering et al., 2001; Brook et al., 2005; Magda et al., 2012). This
would tend to reduce the chances of finding a strong correlation. This high variability of
the %FMD measure, in part, inspired the use of NIRS measures of StO 2 in combination
with a VOT for assessing microvascular reperfusion and reactivity. An advantage of using
NIRS measures is that they have been shown to be highly reliable both within and between
days. Gomez et al. (Gómez et al., 2008) studied the repeatability of NIRS measurements

42

of StO2 in combination with a VOT in healthy controls. They reported high reproducibility
of StO2 for three VOTs performed within the same day (CV 14.2 ± 9.2%), as well as high
reliability for tests 6 months apart (CV 21.2 ± 16.4%). The present study found similar
values for the CV of Slope 2 StO2 (CV 11.0 ± 7.8%), which were lower than those for
%FMD (CV 29.3 ± 13.2%). Another advantage of utilizing the NIRS technique is the ease
with which changes in microvascular reactivity can be assessed at the level of the muscle
instead of solely relying on conduit artery estimates of vascular reactivity.
At the onset of vascular occlusion (i.e. cuff inflation) the metabolic activity of the
muscle leads to a linear decline in StO2, Slope 1 StO2, which is said to reflect the oxygen
extraction (i.e., the metabolic rate) of the tissue. The minimum StO2 attained during
occlusion is considered to indicate the extent of ischemia attained during the set occlusion
period. Mayeur et al. (Mayeur et al., 2011) reported that Slope 2 StO2 is influenced by the
extent of StO2 desaturation, showing a strong correlation between the minimum StO2 and
Slope 2 StO2 during a 3 minute occlusion period in healthy young adults. Previously, De
Blasi et al. (De Blasi et al., 1994) reported that Slope 2 StO2 is metabolism-dependent and
strongly correlates to Slope 1 StO2, such that a greater metabolic accumulation during
ischemia results in a greater reperfusion response of Slope 2 StO2. The present study did
not find a significant correlation between Slope 2 StO2 and either the minimum StO2 or
Slope 1 StO2. This is likely due to the longer occlusion period used in the present study.
The 3 minute occlusion period used in previous studies allowed for a range of desaturation
levels to be attained, however all of the participants in the present study reached what might
be considered a maximal desaturation level by the end of the 5 minute occlusion period.
All of the participants reached a StO2 close to 40%, which is the lowest value typically
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reported in the literature (Doerschug et al., 2007; Mayeur et al., 2011). For a correlation
to be shown a range of occlusion periods would need to be used to reach varying levels of
desaturation. In the present study a 5 minute occlusion period was used as that is the
standardized occlusion period recommended for optimal determination of the endothelialdependent vasodilatory response of FMD (Thijssen et al., 2011a).
The present study was performed using healthy young adult men with no history of
vascular impairment. Although results from previous research using patient populations
support the present results, it is possible that this technique may not be applicable to other
clinical populations (i.e., patients with a flow-limiting stenosis). In addition to the patient
conditions, there are other factors to consider that may alter the StO2 response such as blood
viscosity and alterations in hemoglobin that would change the indirect relationship of StO2
and endothelial function as assessed by FMD. Although these results are promising, further
research is required to confirm that the results from the present study would extend to other
populations.
In conclusion, this study was able to establish a significant correlation between the
NIRS-derived measure of Slope 2 StO2 and ultrasound-derived %FMD. The data support
the notion that NIRS-derived measures of StO2 obtained directly at the microvascular level
are reflective of the microvascular reperfusion and reactivity as measured via FMD in the
conduit artery. The ease of use, good reproducibility, cost-efficiency and low invasiveness
of this technique make it a promising application for assessing vascular responsiveness and
for monitoring changes in vascular responses to various interventions (i.e., exercise
training, diet or pharmacological) in the leg, as previously proposed for other regions of
the body.
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CHAPTER III: Repeatability of vascular responsiveness measures derived from
near-infrared spectroscopy

Introduction
Impaired endothelial-dependent vasodilation is an important feature of vascular
disease and is strongly associated with several chronic cardiovascular conditions
(Neunteufl et al., 2000; Perticone et al., 2001; Kuvin et al., 2001; Gokce et al., 2002;
Modena et al., 2002; Widlansky et al., 2003). The reactive hyperemia endothelial function
test, commonly referred to as a flow-mediated dilation (FMD) test, is a widely used, noninvasive technique which provides insight into peripheral conduit artery vasoreactivity and
information about the integrity and function of the endothelium (Vita & Keaney, 2002).
The FMD technique, typically assessed in peripheral conduit arteries such as the
brachial (Betik et al., 2004), radial (Brook et al., 2005), superficial femoral (Kooijman et
al., 2008), and popliteal (Green et al., 2010), has increasingly been applied in both clinical
and physiological studies. Although FMD is an important tool in assessing vascular and
endothelial function, there is some concern regarding the reliability of the measurement.
Some studies have reported that the test-retest repeatability of %FMD, as measured by the
coefficient of variation (CV) statistic, can be markedly worse than that of the baseline and
peak diameters (Herrington et al., 2001). Additionally, other studies have shown that
%FMD may be a satisfactory (Peretz et al., 2007), or a very poor (Brook et al., 2005),
indicator of vascular function due to high variability between repeated measures.
A new approach to assess vascular responsiveness has emerged with the use of
near-infrared spectroscopy (NIRS).

Recently, tissue oxygen saturation (StO2) was

measured distal to the occlusion site during a FMD test and the NIRS-derived reperfusion
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slope immediately following ischemia (Slope 2 StO2) was indicated to be a good measure
of vascular responsiveness (McLay et al., 2016a), which could be used to test responses to
various interventions (i.e., exercise training, diet or pharmacological). Additionally, this
new approach to assess vascular function can be easily employed in the leg, something that
is more difficult with FMD due to the small diameter changes relative to the large vessel
diameter. This is an important feature as being able to evaluate changes in vascular
responsiveness in the regions where those changes are often expected to occur (e.g., in the
lower limbs before and after an exercise training intervention or chronic adaptations to
exercise) might contribute to a better characterization of this response. Furthermore,
measurements of StO2 have been previously conducted in clinical settings and have
reported results that suggest that NIRS-derived measures, specifically the reperfusion rate,
were able to monitor differences in hemodynamic responses. Creteur et al. (Creteur et al.,
2007a) found that the reperfusion slope was higher in patients with severe sepsis who
survived than in non-survivors. Additionally, they reported that the reperfusion slope
tended to increase in survivors over the observation period but not in non-survivors.
With the increasing use of noninvasive techniques to assess vascular
responsiveness both in clinical settings and in physiological research, it is important to have
a better understanding of the reliability of measures being used. To our knowledge, no
study to date has systematically evaluated the day-to-day (interday) and test-to-test
(intraday) reliability of the recently proposed measurement of vascular reactivity (Slope 2
StO2) in the leg, or compared the reliability to that of %FMD in the popliteal artery, which
is a necessary step if this new approach is to be applied to compare responses before and
after an intervention or simply at different time points. Therefore, the main purpose of the
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present study was to examine the test-to-test reliability (variability between repeated tests
within a single day) and day-to-day reliability of the NIRS-derived measure Slope 2 StO2;
by calculating the repeatability, which is a measure of absolute reliability and used to
examine the influence of measurement errors (Bland & Altman, 1996). A secondary aim
of this study was to compare the reliability of Slope 2 StO2 to that of the widely used FMD
measurement.
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Methods
Participants
Nine healthy young men (mean ± SD, age: 26 ± 3 yr; mass: 82 ± 8 kg; height: 178
± 4 cm) volunteered and gave written consent to participate in the study. All procedures
were approved by The University of Western Ontario Research Ethics Board for Health
Sciences Research Involving Human Subjects. All participants were recreationally active
(i.e., meeting the recommended guidelines for physical activity (Tremblay et al., 2011))
and non-smokers. Additionally, all subjects were normotensive (mean blood pressure ±
SD: systolic 124 ± 7 mmHg; diastolic 66 ± 7 mmHg) and no subjects were taking
medications that would affect hemodynamic responses.
Study Design
A series of FMD tests were performed on each participant over five consecutive
days, with NIRS-derived measures of StO2 obtained throughout the duration of each test.
All tests were performed in an environment where temperature was controlled throughout
the testing protocol (20-22ºC) and at the same time each day to minimize diurnal effects.
All participants were instructed to refrain from caffeine, alcohol and exercise for >12 hours
prior to their scheduled visit. One FMD test was performed on each of four days, with a
fifth day involving three FMD tests. The day when three FMD tests were performed was
randomized between subjects and each of the three FMD tests were separated by a 30
minute rest period to allow blood flow and arterial dilation to return to resting conditions
(Harris et al., 2006). Each FMD test was performed with an occlusion pressure of 250
mmHg.
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Near-infrared spectroscopy
StO2 of the tibialis anterior muscle was monitored continuously throughout each
FMD test with a frequency-domain multi-distance NIRS system (Oxiplex TS, ISS,
Champaign, Ill., USA). Briefly, the system was composed of a single channel consisting
of 8 laser diodes operating at 2 wavelengths (λ = 690 and 828 nm, 4 at each wavelength),
which were pulsed in rapid succession, and a photomultiplier tube. The lightweight plastic
NIRS probe (connected to laser diodes and a photomultiplier tube by optical fibers)
consisted of 2 parallel rows of light emitter fibers and 1 detector fiber bundle; the sourcedetector separations for this probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. The
probe was placed on the belly of tibialis anterior the muscle (midway between the knee and
the ankle), was secured in place with an elastic strap tightened to prevent movement and
was covered with an optically dense, black vinyl sheet, thus minimizing the intrusion of
extraneous light.

An elastic bandage was applied to further minimize intrusion of

extraneous light and probe movement. A pneumatic cuff (Adult 11 long, Flexiport; Welch
Allyn Inc., Skaneateles Falls, NY, USA) was placed just below the knee, above but not
over the secured NIRS probe. By measuring changes in light absorption at different
wavelengths, changes in oxyhemoglobin (HbO2) and deoxyhemoglobin (HHb) can be
measured continuously, and StO2 can be calculated (defined as [HbO2] / [HbO2 + HHb]).
NIRS measurements were collected continuously for the entire duration of each FMD test
(2 min baseline, 5 min occlusion and 5 min post-release) plus an additional 3 minutes
following cuff release to ensure StO2 fully returned to baseline levels (for a total of 8
minutes post-release).
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The NIRS device was calibrated at the beginning of the first test session following
an instrument warm-up period of at least 20 min. The calibration was done with the probe
placed on a calibration block (phantom) with absorption (μa) and reduced scattering
coefficients (μs’) previously measured; thus, correction factors were determined and were
automatically implemented by the manufacturer’s software for the calculation of the μa and
μs’ for each wavelength during the data collection. Calculation of [HbO2] and [HHb]
reflected continuous measurements of μs’ made throughout each testing session (i.e.,
constant scattering value not assumed). The probe remained secured to the leg throughout
the duration of the visit to ensure measurement consistency between both FMD tests. Data
were stored online at an output frequency of 2 Hz, but were reduced to 1 s bins for all
subsequent analyses within the present study.
Baseline StO2 (%) was calculated as the average of 1 min of StO2 prior to ischemia.
Minimum StO2 (%) was calculated as the lowest StO2 value attained during ischemia. The
StO2 reperfusion rate was quantified as the upslope of a 10 second window immediately
following cuff release of the StO2 signal (Slope 2 StO2, %∙s-1); the reperfusion rate
immediately following cuff release is a relatively linear response which allows for a simple
slope calculation. Peak StO2 (%) was calculated as the highest StO2 value reached
following cuff release (McLay et al., 2016a).
Popliteal artery assessments
FMD of the popliteal artery was assessed in accordance with previously published
guidelines for the current standardized methodology (Corretti et al., 2002; Thijssen et al.,
2011a). Following at least 10 minutes of supine rest, participants were instructed to lie
prone as ultrasound imaging was performed on the back of the knee. A small pillow was
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placed under the participant’s ankle for comfort and optimization of the knee angle so there
was no leg movement throughout the cycles of the FMD tests. The left popliteal artery was
imaged immediately proximal to the bifurcation (usually at or slightly above the popliteal
fossa), and a pneumatic cuff (Flexiport; Welch Allyn Inc., Skaneateles Falls, NY, USA)
was placed around the calf (approximately 5 cm distal to the popliteal fossa). Heart rate
was continuously monitored with a three-lead ECG to allow for consistent and accurate
selection of arterial diameter measurements at the end of the diastolic phase of the cardiac
cycle.
The popliteal artery was imaged with a 10-MHz multifrequency linear-array
transducer attached to a Doppler ultrasound machine (VingMed System FiVe, GE Medical
Systems, Horten, Norway). All scans were performed by an experienced investigator. All
scans were made with similar ultrasound settings and all images were recorded on an
external video camera (HDD Everio; JVC, Canada) for later offline analysis. Baseline
diameter was recorded prior to manual inflation of the pneumatic cuff. The cuff was then
inflated for 5 minutes to an occlusion pressure of 250 mmHg, during which diameter was
not recorded. Fifteen seconds prior to release of the cuff the video camera resumed
recording and at exactly 5 minutes after inflation, the pneumatic cuff was released and
arterial diameter was continuously monitored for 5 minutes post-release.
Diameter measurements, defined as the distance between the media and intima
interface of the near wall and far wall, were obtained using a caliper that converted image
pixels to millimeters. Triplicate measurements of diameter were taken for each of five
baseline images and averaged to determine the baseline diameter of the artery. Similarly,
triplicate measurements of diameter were averaged for images taken every 15 seconds
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following cuff release. Peak diameter was determined as the post-occlusion image with
the largest diameter and percent flow-mediated dilation (%FMD) was then calculated as
the percent change in diameter from baseline.
Statistical Analysis
All statistical analyses were performed using SPSS software, version 19 (SPSS Inc.,
Chicago, Ill., USA) and Microsoft Excel 2010 (Microsoft, Seattle, Wash., USA).
Group mean, standard deviation (SD) and coefficient of variation (CV = SD/mean
× 100) were calculated for NIRS- and ultrasound-derived parameters for each test. A oneway repeated measures analysis of variance (ANOVA) was used to determine if there were
significant differences within the variables of the five NIRS and FMD tests performed over
consecutive days, and the three NIRS and FMD tests performed within the same day. The
repeatability, also known as the coefficient of repeatability, of each variable for the
comparisons was calculated by multiplying the within-subject standard deviation (Sw) by
2.77 [or (1.96 × √2) × Sw] (Bland & Altman, 1996). The repeatability represents the
critical value at which a measurable change is observed in a given participant between tests.
Reliability of three FMD tests repeated in a single day and the five tests performed over
consecutive days were assessed using the intraclass correlation coefficient (ICC), which
was based on the repeated measures ANOVA with testing session as the independent
variable (Shrout & Fleiss, 1979). For statistical tests p < 0.05 was considered significant.

56

Results
NIRS: Group means and standard deviation for StO2 parameters for within and betweenday comparisons are listed in Tables 3.1 and 3.2, respectively. There was no significant
difference in Slope 2 StO2 between tests performed within a single day, or across five days.
Repeatability values for the intraday and interday comparisons were 0.43 and 0.48,
respectively; which represents that 33% and 36% of the mean value could be attributed to
measurement error. ICC for the intraday and interday comparisons were 0.92 and 0.94,
respectively. CV for the intraday and interday comparisons were 9 ± 4% (range 3 – 15%)
and 14 ± 5 (range 9 – 24). Figure 3.1 shows the average profile for each of three tests
performed in a single day (Panel A), as well as the variation in Slope 2 StO2 values for each
individual and group means (Panel B). Figure 3.2 shows the average profile for each of
the five tests performed over five days (Panel A), as well as the variation in Slope 2 StO2
values for each individual and group means (Panel B).
FMD: Group means and standard deviation for baseline diameter, peak diameter and
%FMD for within and between-day comparisons are listed in Tables 3.1 and 3.2,
respectively. There was no significant difference for %FMD between tests performed
within a single day, or across five days. Repeatability values for the intraday and interday
comparisons were 5.62 and 4.82, respectively; which means that greater than 100% of the
mean value for FMD could be attributed to measurement error both within and between
days. ICC for the intraday and interday comparisons were 0.36 and 0.25, respectively. CV
for the intraday and interday comparisons were 44 ± 24% (range 7 – 79%) and 40 ± 22%
(range 3 – 88%). Figure 3.3 shows the variation in %FMD values for each individual, as
well as group means, for three tests within a single day (Panel A) and five tests across five
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days (Panel B).
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Table 3.1. Ultrasound- and NIRS-derived measurements throughout a vascular occlusion
test for three tests performed in a single day.

Test 1

Test 2

Test 3

6.5 ± 0.7
6.8 ± 0.7
4.5 ± 2.5

6.7 ± 0.5
6.9 ± 0.6
3.1 ± 2.0

6.6 ± 0.8
6.9 ± 0.8
5.6 ± 3.5

69.6 ± 1.7
46.0 ± 6.6
81.5 ± 1.8
1.24 ± 0.25

71.1 ± 2.4
46.2 ± 7.5
82.1 ± 1.4
1.32 ± 0.38

70.7 ± 2.9
45.9 ± 7.5
82.2 ± 2.0
1.32 ± 0.33

Ultrasound-derived
Measures
Baseline diameter (mm)
Peak diameter (mm)
Flow-mediated dilation (%)

NIRS-derived Measures
Baseline StO2 (%)
Absolute Minimum StO2 (%)
Absolute Peak StO2 (%)
Slope 2 StO2 (%∙s-1)

Notes: Values are means ± standard deviations.
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Table 3.2. Ultrasound- and NIRS-derived measurements throughout a vascular occlusion test for five tests performed across five days.
Day 1

Day 2

Day 3

Day 4

Day 5

6.7 ± 0.7
6.9 ± 0.6
3.1 ± 2.0

6.7 ± 0.5
6.9 ± 0.6
3.5 ± 1.6

6.7 ± 0.6
7.0 ± 0.6
4.8 ± 1.8

6.5 ± 0.5
6.8 ± 0.5
4.5 ± 2.3

6.7 ± 0.5
7.0 ± 0.4
4.5 ± 2.0

71.1 ± 2.4
46.2 ± 7.5
82.1 ± 1.4
1.32 ± 0.38

71.7 ± 3.6
46.6 ± 9.9
83.4 ± 2.7
1.38 ± 0.41

72.3 ± 2.6
49.2 ± 5.9
82.7 ± 1.7
1.37 ± 0.35

70.4 ± 4.0
46.6 ± 8.0
82.8 ± 2.5
1.39 ± 0.40

70.4 ± 3.5
46.1 ± 7.7
81.5 ± 4.5
1.30 ± 0.40

Ultrasound-derived Measures
Baseline diameter (mm)
Peak diameter (mm)
Flow-mediated dilation (%)

NIRS-derived Measures
Baseline StO2 (%)
Absolute Minimum StO2 (%)
Absolute Peak StO2 (%)
Slope 2 StO2 (%∙s-1)

Notes: Values are means ± standard deviations.
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Figure 3.1. A) Group average tissue oxygen saturation profile for three vascular occlusion
tests performed within the same day; B) Group mean values for Slope 2 StO2 each day are
represented by the thick black lines, with each open circle and connecting line representing
an individual subject.
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Figure 3.2. A) Group average tissue oxygen saturation profile for each of five vascular
occlusion tests performed on separate days; B) Group mean values for Slope 2 StO2 each
day are represented by the thick black lines, with each open circle and connecting line
representing an individual subject.
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Figure 3.3. A) Group mean values for each of three FMD tests performed in a single day
are represented by the thick black lines, with each open circle and grey line representing
an individual subject; B) Group mean values and individual data for each of five FMD tests
performed across five days.
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Discussion
The main goal of this study was to investigate the test-to-test (intraday) and day-today (interday) reliability of the NIRS-derived Slope 2 StO2 and compare it to that obtained
from ultrasound-derived %FMD of the popliteal artery. The main findings were as follows:
1) the reliability of the Slope 2 StO2 measure was strong both within and between testing
days (low repeatability values, high ICCs, and low CV); 2) the reliability of %FMD, at
least in the artery measured in this study, was poorer than that observed for the StO2, both
within and between testing days, as indicated by high repeatability values, low ICCs, and
high CV.
Although NIRS-derived measures of StO2 have been shown to reflect vascular
responsiveness (McLay et al., 2016a), and they have been used to measure StO2 in healthy
and clinical populations previously (Doerschug et al., 2007; Creteur et al., 2007a), the
present study was the first to comprehensively examine the reliability of the NIRS-derived
parameter Slope 2 StO2 in the leg. This is important as repeatability is used to examine the
influence of measurement errors on data analysis and is an indicator of absolute reliability
(Bland & Altman, 1996), which is necessary to know when interpreting changes in
response to an intervention or as a consequence of factors such as training status, disease,
etc. In the present study, small values for repeatability indicated strong reliability of the
measures. Repeatability values were indicative of strong reliability of the measure for both
intraday (0.43) and interday (0.48) comparisons, with approximately 30% of the
measurement potentially being influenced by measurement error. This study also reported
the ICC, which provides a measure of relative reliability. As suggested by Portney and
Watkins (Portney & Watkins, 2000), ICC values >0.75 are considered to be reliable. In
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the present study, ICC values for intraday (0.92) and interday (0.94) reliability of Slope 2
StO2 indicated very strong reliability of the technique. Similarly, CV was indicative of
strong reliability of the measure both within (9 ± 4%) and between days (14 ± 5%).
Comparable CV values for Slope 2 StO2 in the leg were previously reported by McLay et
al. (McLay et al., 2016a); however, of note, in that study the CV was derived from only
two tests performed in a single day. The present study examined the reliability not only
within a single day (with three repeats) but also across multiple days, something of
particular value for intervention-type studies. These results are consistent with a previous
study that reported the CV of StO2 in combination with vascular occlusion in the thenar
eminence of healthy controls. Gómez et al. (Gómez et al., 2008) reported high reliability
of StO2 for three occlusion tests performed within the same day (CV 14.2 ± 9.2%). The
present study examined the reliability of the Slope 2 StO2 in a more systematic way than
Gómez et al. and also reported strong day-to-day reliability for tests performed on five
consecutive days.
In this study, Slope 2 StO2, a relatively new approach to assessing vascular
responsiveness which has been shown to significantly correlate to %FMD (McLay et al.,
2016a), showed better reliability than that of the widely used measure of FMD.
Repeatability values were high for intraday and interday FMD such that a difference of
5.6% and 4.8% respectively would be needed to observe a change in FMD that would not
be associated with measurement error of the technique. These values for repeatability are
as large as the mean FMD measures themselves. Similarly, ICC values for both intraday
(0.36) and interday (0.25) comparisons were indicative of poor reliability. It has to be
acknowledged that the present study utilized the popliteal artery for FMD measures, which
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could result in poorer reliability as compared to what might be observed in arteries that are
more commonly assessed, such as the brachial or the radial artery. However, it has to be
noted that poor reliability has been reported in other measurement sites as well. Hardie et
al. (Hardie et al., 1997) demonstrated that reproducibility of brachial artery FMD was poor
and likely to provide inaccurate measurements for two FMD tests separated by an average
of 90 days. Repeatability calculated from reported values for within subject SD indicated
that changes in FMD in the brachial artery would need to be approximately 19% to be able
to detect differences that could not be attributed to measurement error. Similarly, Brook
et al. (Brook et al., 2005) assessed intra- and interday reliability for two FMD tests
performed in the same day and two tests performed approximately 7 days apart. The
repeatability values were high for both intraday (11%) and interday (11%). Thus, even
though the relevance of the %FMD as a measure of vascular responsiveness is undeniable,
this lack of reliability that is often acknowledged in the literature and that it is also
supported by this current experimental data set, might be one of the factors contributing to
the lack of differences in %FMD between groups that were expected to show different
responses (Birk et al., 2013; Atkinson & Batterham, 2013). A measure such as the Slope
2 StO2 can contribute to the study of non-invasive assessment of vascular responsiveness
not only by providing another technique that can estimate vascular reactivity within the
microvasculature, but also by offering the possibility of detecting between group
differences more easily (i.e., needing a lower number of participants) thanks to the greater
reliability of this measure.
The measurement of StO2 throughout a vascular occlusion has been previously used
in clinical settings to monitor recovery of patients. Studies have shown significant
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differences between the reperfusion rate of the StO2 signal (Slope 2 StO2) of septic patients
and healthy controls, with the septic patients having a much slower reperfusion following
cuff release than that of controls (Doerschug et al., 2007).

Additionally, repeated

measurements of Slope 2 StO2 in intensive care patients has shown that slopes increase
over time in surviving patients, but not in non-survivors (Doerschug et al., 2007). These
studies, in combination with recent demonstration of the association between Slope 2 StO2
and %FMD (McLay et al., 2016a), demonstrate the ability of this measure to detect
differences in vascular and hemodynamic responses.
Vascular impairments at both the macro- and the micro-circulatory level are known
to be associated with cardiovascular disease (CVD) (Lloyd-Jones et al., 2010). As such,
proper assessment of vascular responsiveness becomes an important instrument for early
detection of pre-clinical dysfunction, diagnosis, monitoring of treatment efficacy and
possibly prevention of CVD. The use of NIRS allows for changes in microvascular
reactivity to be assessed at the level of the muscle instead of solely relying on conduit artery
estimates of vascular reactivity. This is an important feature as some forms of CVD have
been indicated to originate with functional limitations within the microcirculation (Seals,
2014). Thus, detecting problems where they originate may help early detection of future
cardiovascular complications. In the present study, assessing vascular responsiveness in
the leg was an important factor when selecting the area of FMD and NIRS interrogation as
several training intervention are predominately lower limb exercises (such as cycling and
running) and thus, even though it is acknowledged that changes in vascular reactivity can
extend to other areas, it is important to be able to assess vascular responsiveness in the
region that is more affected by the proposed intervention.
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Nonetheless, with any

measurement technique it is important to understand the degree to which differences in
measures may be attributed to physiological adaptations to various interventions or
clinically meaningful changes instead of reflecting measurement error.

The strong

reliability of this new technique to measure vascular responsiveness, taken together with
the previously established capability of tracking changes in hemodynamic responses,
makes it a promising application for assessing vascular responsiveness, complimenting the
assessment of endothelial health, and in monitoring responses to various interventions.
A criticism of the present study could be that %FMD was calculated from diameter
measurements made every 15 seconds, as the most recent recommendations for the analysis
of FMD stipulate the use of edge-tracking software for the assessment of arterial diameters
for each cardiac cycle in the post-occlusive period. A previous analysis comparing manual
and edge-tracking software (data not presented) found that there was no difference between
FMD values obtained through the two analysis methods. Additionally, although the
automated edge-tracking software does include more diameters for the determination of
%FMD, there is more noise in the data as a result of the variability in the greater number
of diameters which results in poorer reliability of the measure derived from the edgetracking software. In this context, the values reported here are derived from the less
variable %FMD of the manual analysis to avoid exacerbating the low repeatability of the
FMD measure. The present study did not focus on the reliability of the FMD measure but
instead emphasizes the strong reliability of the new approach to assessing vascular
reactivity (i.e., NIRS-derived measures of Slope 2 StO2).
The present study also reports values for Baseline StO2, Minimum StO2 and Peak
StO2 as a reference for future studies. It should be noted that the static values for StO2 are
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not “corrected” for adipose tissue thickness (ATT), which has been suggested to influence
the measurement of these values (Niwayama et al., 2000). Nevertheless, while ATT may
influence the absolute values of StO2 obtained for certain parameters it has been reported
that dynamic changes, such as Slope 2 StO2, should not be affected as the changes are
independent of absolute values (Bopp et al., 2011). That being said, the TA muscle offers
an ideal sight of measurement for NIRS as there is often less adipose tissue overlying the
muscle compared to other muscles in the leg.
In conclusion, this study demonstrated that the NIRS-derived Slope 2 StO2, a
measure established to reflect vascular reactivity (Doerschug et al., 2007; Creteur et al.,
2007a; McLay et al., 2016a), has strong reliability. The reliability of this new approach
for non-invasively assessing vascular responsiveness has important implications for the
assessment of vascular responsiveness as it might contribute in determining differences
between groups or before and after an intervention that would be otherwise difficult to
establish.
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CHAPTER IV: Is allometric scaling necessary for the accurate assessment of flowmediated dilation in young healthy men?

Introduction
Impaired endothelial-dependent vasodilation is an important feature of vascular
disease and is strongly associated with several chronic cardiovascular (CV) conditions
(Neunteufl et al., 2000; Perticone et al., 2001; Kuvin et al., 2001; Gokce et al., 2002;
Modena et al., 2002; Widlansky et al., 2003). The reactive hyperemia endothelial function
test, commonly referred to as a flow-mediated dilation (FMD) test, is a widely used, noninvasive technique which provides insight into peripheral conduit artery vasoreactivity and
provides information about the integrity and function of the endothelium (Vita & Keaney,
2002). The FMD technique, typically assessed in peripheral conduit arteries such as the
brachial (Betik et al., 2004; Pyke et al., 2008; Weissgerber et al., 2011; Szijgyarto et al.,
2013), radial (Pyke et al., 2009), superficial femoral (Kooijman et al., 2008; Totosy de
Zepetnek et al., 2014), and popliteal (Parker et al., 2006; McLay et al., 2016a), has
increasingly been applied in both clinical and physiological studies. The FMD test has been
documented to correlate with invasively assessed endothelial function in the coronary
arteries (Takase et al., 1998a), and appears to be predictive of CV events in asymptomatic
subjects (Fathi et al., 2004) and those with established cardiovascular disease (CVD)
(Neunteufl et al., 2000). The primary outcome measure of the FMD test is the change in
arterial diameter from baseline (Dbase) to a post-ischemic peak diameter measurement
(Dpeak). This change (Ddiff) is then expressed as a percentage of Dbase (Eq. 1) and that is the
value (%FMD) commonly reported by researchers over the past two decades.
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%𝐹𝑀𝐷 =

(𝐷𝑝𝑒𝑎𝑘 −𝐷𝑏𝑎𝑠𝑒 )
𝐷𝑏𝑎𝑠𝑒

× 100

(1)

Although FMD is a widely used measure, limitations have been acknowledged such
as poor reliability (Hardie et al., 1997; Brook et al., 2005) and bias towards Dbase, such that
the Dbase of the vessel is going to influence the %FMD response. In this regard, Atkinson
et al. (2013) have suggested that the traditional calculation of FMD as a % change from
baseline violates statistical assumptions and introduces an element of error, because the
dilatory response is very small in relation to the Dbase. Dbase has been negatively correlated
to %FMD (Thijssen et al., 2008) such that individuals with larger values for Dbase (i.e.,
diseased populations) have lower %FMD, and vice versa. However, although Dbase is often
higher in diseased versus healthy populations (Yeboah et al., 2007, 2009), Dbase can also
become larger in response to many interventions, including regular exercise (Birk et al.,
2013). This may account for the difficulty in explaining certain results; for example,
trained and untrained individuals having similar %FMD values. Atkinson et al. (2013)
have proposed the use of allometric scaling of FMD to eliminate the dependency of %FMD
on Dbase. The Atkinson scaling technique employs a log-linked generalized linear model
with the absolute change in diameter (Ddiff) as the outcome and logarithmically transformed
Dbase as a covariate. This approach yields ‘corrected’ group mean values for %FMD by
dividing the covariate-adjusted mean of Ddiff by the antilog of Dbase, for conventional
interpretation in percentage terms. Although the ANCOVA model to generate ‘corrected’
group means has value when assessing FMD in different populations, with different Dbase,
this technique is also being proposed for application in populations where no difference in
Dbase exists.
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Additionally, the ANCOVA model only generates ‘corrected’ group mean values
for %FMD and a single standard deviation (SD) shared by all groups with no indication of
FMD from the individual tests. To allow for the calculation of scaled FMD values for
individual tests the authors also outline a calculation which requires the slope of the
relationship between logarithmically transformed Dbase and Dpeak (Atkinson et al., 2013).
This slope value, m, is proposed as the correct allometric exponent for scaling purposes in
a given population, such that individually scaled FMD for each participant can be
calculated by dividing Dpeak by Dbasem (eq. 2).
𝐷

Atkinson scaling 𝐹𝑀𝐷 = 𝐷 𝑝𝑒𝑎𝑘𝑚

(2)

𝑏𝑎𝑠𝑒

Preliminary analysis from individual data indicated that these individual values
were substantially different from the ‘corrected’ means for FMD derived from the
ANCOVA model, such that the values for the individuals were larger than would make
physiological sense based on previously reported data. This led us to further investigate
the use of the Atkinson scaling FMD calculation for individual participants and, eventually,
to consider a new approach for individually scaling FMD (eq. 3).
New scaling 𝐹𝑀𝐷 =

𝐷𝑝𝑒𝑎𝑘 −𝐷𝑏𝑎𝑠𝑒
𝐷𝑏𝑎𝑠𝑒𝑚

× 100

(3)

Thus, the purpose of the present study was to examine if the employment of the
new scaling FMD calculation improved the ability to obtain individual FMD values that
are corrected for variations in Dbase. We hypothesized that individual FMD values obtained
from the new scaling FMD calculation would yield FMD values that were close to those
typically presented for FMD, while still obtaining the benefits of controlling for Dbase.
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Methods
Participants
Eighteen healthy young men (mean ± SD, age: 26 ± 3 yr; mass: 82 ± 7 kg; height:
181 ± 5 cm) volunteered and gave written consent to participate in the study. All
procedures conformed to the standards set by the latest revision of the Declaration of
Helsinki and were approved by The University of Western Ontario Research Ethics Board
for Health Sciences Research Involving Human Subjects.

All participants were

recreationally active (i.e., meeting the recommended guidelines for physical activity
(Tremblay et al., 2011)) and non-smokers. Additionally, all subjects were normotensive
(mean blood pressure ± SD: systolic 124 ± 7 mmHg; diastolic 68 ± 6 mmHg) and no
subjects were taking medications that would affect hemodynamic responses.
Experimental Protocol
FMD of the popliteal artery was assessed in accordance with previously published
guidelines for the current standardized methodology (Corretti et al., 2002; Thijssen et al.,
2011a). All participants were instructed to refrain from caffeine, alcohol and exercise for
>12 hours prior to their scheduled appointments and all tests were performed in an
environment where temperature was controlled throughout the testing protocol (21 ºC).
Following 10 minutes of supine rest, participants were instructed to lie prone as ultrasound
imaging was performed on the back of the knee; a small pillow was placed under their
ankle for comfort and optimization of the knee angle so there was no leg movement
throughout the cycles of the FMD tests. The left popliteal artery was imaged immediately
proximal to the bifurcation (usually at or slightly above the popliteal fossa), and a
pneumatic cuff (Flexiport; Welch Allyn Inc., Skaneateles Falls, NY, USA) was placed
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around the calf (approximately 5 cm distal to the popliteal fossa).

Heart rate was

continuously monitored with a three-lead ECG to allow for consistent and accurate
selection of arterial diameter measurements at the end of the diastolic phase of the cardiac
cycle.
The popliteal artery was imaged with a 10-MHz multifrequency linear-array
transducer attached to a Doppler ultrasound machine (VingMed System FiVe, GE Medical
Systems, Horten, Norway). All scans were performed by the same investigator who had
completed specific training for the performance of FMD tests. Ultrasound settings were
kept the same between all FMD tests and all images were recorded on an external video
camera (HDD Everio; JVC, Canada) for later offline analysis. Baseline diameter was
recorded prior to manual inflation of the pneumatic cuff. The cuff was then inflated to 250
mmHg for 5 minutes, during which diameter was not recorded. At 15 seconds prior to
release of the cuff the video camera resumed recording. At exactly 5 minutes after
inflation, the pneumatic cuff was released and arterial diameter was continuously
monitored for 5 minutes post-release.
Popliteal Artery Diameter Analysis
Commercially available software (Sante DICOM Editor, Version 3.2.1; Santesoft,
Athens, Greece) was used to extract the end-diastolic frames, determined by the R-spike
of the ECG trace, and stack them in a new DICOM file for determination of popliteal artery
diameters. Diameters at end-diastole were determined with a semi-automated edge
detection software program (Artery Measurement System Image and Data Analysis,
Gothenburg, Sweden). Baseline diameter (Dbase) was determined from the average of ten
end-diastole frames. Post-release diameters were averaged into 5-second time bins (Origin,
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OriginLab Corp., Northampton, Massachusetts, USA). Peak diameter (Dpeak) was
determined as the largest post-occlusion diameter.
FMD was calculated in each of three ways, where Dpeak is the largest post-ischemic
diameter, Dbase is the average diameter prior to cuff-inflation, and m is the slope of the
relationship between logarithmically transformed Dbase and Dpeak;
1) Traditional calculation: %𝐹𝑀𝐷 =

(𝐷𝑝𝑒𝑎𝑘 −𝐷𝑏𝑎𝑠𝑒 )
𝐷𝑏𝑎𝑠𝑒

× 100

𝐷

2) Atkinson scaling: %𝐹𝑀𝐷 = 𝐷 𝑝𝑒𝑎𝑘𝑚
𝑏𝑎𝑠𝑒

3) New scaling: %𝐹𝑀𝐷 =

𝐷𝑝𝑒𝑎𝑘 −𝐷𝑏𝑎𝑠𝑒
𝐷𝑏𝑎𝑠𝑒𝑚

× 100

Statistical Analysis
Group means and SD were calculated for the FMD statistics derived from each of
the three different calculations. Correlations (Pearson product moment) between Dbase and
each of the three FMD calculations were calculated using SigmaPlot 11.0 (Systat Software,
Inc., SanJose, CA, USA).
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Results
The means and SD for Dbase, Dpeak and each of the three FMD calculations are listed
in Table 4.1. The slope of the relationship between logarithmically transformed Dbase and
Dpeak was 0.94 (Figure 4.1).
Figure 4.2 illustrates the relationship between Dbase and each of the three FMD
calculations. The traditional FMD had a very weak correlation (r = 0.0161). Employment
of the Atkinson scaling FMD resulted in more positive correlation (r = 0.2104). The New
scaling FMD resulted in a weaker correlation than that of the traditional FMD calculation
(r = 0.0029).
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Table 4.1. Variables measured during the flow-mediated dilation protocol based on
individual values.

Baseline diameter, Dbase (mm)
Peak diameter, Dpeak (mm)
Traditional FMD Calculation (%)
Atkinson scaling FMD Calculation (%)
New scaling FMD Calculation (%)
Values are presented in means ± standard deviation
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n = 18
6.96 ± 0.62
7.36 ± 0.68
5.82 ± 2.58
19.25 ± 2.98
6.56 ± 2.91

Figure 4.1. The relationship between logarithmically transformed values for baseline and
peak diameter. The equation for the regression is plotted on the graph; such that the
regression slope is 0.94.
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Figure 4.2. The correlation between values of Dbase and calculated %FMD for the
traditional FMD (A), Atkinson Scaling FMD (B) and New scaling FMD (C). There is no
negative correlation between Dbase and the traditional FMD, which results in a more
positive correlation with the employment of the Atkinson scaling. The new scaling FMD
results in a correlation less positive than the traditional FMD calculation.
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Discussion
The main goal of this study was to examine the relationship between the Atkinson
scaling FMD and traditional FMD values and determine if the employment of the new
scaling FMD calculation improved the ability to obtain individual FMD values that are
corrected for variations in Dbase. The main finding was that the average %FMD from the
individual values derived from the Atkinson scaling FMD calculation were 3-4 fold larger
than meaningful %FMD values that should be expected for this measure. Additionally, the
new scaling calculation for FMD resulted in values that were within the expected %FMD
response for this measure, but did not correct for variation in Dbase as well as the Atkinson
scaling FMD calculation.
FMD is a very common assessment of endothelial function however concerns with
the specificity of the measure in providing useful information has been recently identified,
as the measure is heavily dependent upon Dbase. This concept was identified by leading
laboratories in the area of FMD (Atkinson et al., 2013; Stoner et al., 2013) and ultimately
lead to the proposed use of allometric scaling. Although the scaling method may have
value for evaluating group changes and estimating mean %FMD, the suggestion of
applying it on an individual basis for prognostic and diagnostic purposes has deficiencies.
The individual values derived from the Atkinson scaling calculation are 3-4 times larger
than those of the traditional FMD. The high values of FMD are a concern when FMD is
used as a prognostic or diagnostic tool, because it becomes difficult to establish what a
clinically meaningful differences in %FMD would be. Additionally, the averages of the
individually scaled values differ from those calculated in preliminary analysis from the
proposed ANCOVA model for group means. This discrepancy in the mean values is likely
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due to the fact that mean values are more easily corrected than individual values with this
method of scaling. The ANCOVA model calculates mean values for Ddiff using Dbase as
the covariate, and these values are then back-transformed into percentages for conventional
interpretation. However, the individual FMD values are allometrically scaled for the
participant’s Dbase value which is raised to the power of a slope derived from group data.
The difference between the two mean values, suggested a need to modify the Atkinson
scaling calculation in order to obtain values of FMD that were closer to what would be
expected from this physiological response, while still being scaled for variations in Dbase.
The use of the new scaling calculation for %FMD did result in mean values for each
FMD test that approximated those of the original calculation and those produced by the
ANCOVA model, however the calculation does not account for variation in Dbase as well
as the Atkinson scaling. %FMD has been shown to negatively correlate with Dbase, as
%FMD is based on the premise that Ddiff will vary in proportion with Dbase (Atkinson &
Batterham, 2013). Employment of the Atkinson scaling reduces this bias towards Dbase and
resultant negative correlation, ultimately producing a more positive correlation. Although
the present study did not find a strong negative correlation between %FMD and D base,
employment of the Atkinson scaling resulted in a slightly more positive correlation
indicating a reduction of a dependency on Dbase (Figure 4.2). The relationship between
Dbase and the new scaling FMD produced a similar correlation to that of the traditional
FMD calculation, thereby indicating that the new scaling FMD does not adequately scale
for the variation in Dbase.
Allometric scaling may have value for evaluating differences between groups with
expected differences in Dbase (i.e., comparing children to adults, or diseased and healthy

84

populations), however the question remains as to whether this analysis technique should
be adopted as a standard practice in all FMD studies. As outlined earlier in the discussion,
the present study found no negative correlation between the traditional %FMD and Dbase,
which would suggest that variations in Dbase are not strongly influencing the %FMD values
in this sample group. The present study utilized a rather homogeneous population (i.e.,
healthy young men) in which very little difference in Dbase would be expected; however,
studies involving similar population demographics are being asked to employ allometric
scaling practices to account for variations in Dbase. The results of the present study would
indicate that although allometric scaling has usefulness comparing groups where
differences in Dbase exist, there appears to be no additional value to the application in studies
of a similar population or studies quantifying within-subject effects where no arterial
structural adaptations are expected.
Technical considerations: Although we acknowledge that the FMD technique is more
commonly used to assess endothelial function of the brachial artery, the present study
examined %FMD responses in the popliteal artery. Two reasons prompted this decision:
1) as shown by Parker et al. (2006), the average dilatory response of the popliteal is
markedly less than that of the brachial (8.1 ± 1.5% compared to 14.6 ± 1.9%) which should
result in variation in Dbase having a larger influence on the calculation of popliteal artery
%FMD; 2) several exercise intervention studies prescribe primarily lower body exercises
(i.e., cycling and running). Thus, more information surrounding the assessment of FMD
at a more localized level may be of additional value in interventions that mainly involve
lower limb muscle activity.
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In conclusion, although allometric scaling offers some benefits in that it reduces the
bias of Dbase on the FMD measurement, individual values cannot be calculated, which
reduces the prognostic value of the approach and limits the ability to examine the statistical
relevance of the measure. Additionally, the present study found no advantage to employing
the allometric scaling approach in this population of healthy young individuals. Thus,
recommendations related to the advantages of allometrically scaling the %FMD measure
in homogeneous sample groups should be made with caution until research clearly
establishes the benefits of this approach.
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CHAPTER V: Vascular responsiveness measured by tissue oxygen saturation
reperfusion slope is sensitive to different occlusion durations in healthy trained and
untrained young men

Introduction
Cardiovascular disease (CVD) is presently the leading cause of morbidity and
mortality in so-called developed countries (Lloyd-Jones et al., 2010; Green et al., 2011).
Vascular impairments at both the macro- and the micro-circulatory level are known to be
associated with CVD (Lloyd-Jones et al., 2010).

More specifically, endothelial

dysfunction, commonly expressed as deficiencies in nitric oxide (NO) production and
release by the endothelial cells, and the consequent reduction in vascular responsiveness
has been proposed to play a pivotal role in the advancement of CVD (Langham & Wehrli,
2011). Therefore, it is important to have a means to accurately and non-invasively assess
vascular responsiveness, for early detection of impairment.
Flow-mediated dilation (FMD) via Doppler ultrasound is currently the most widely
used technique to non-invasively assess vascular responsiveness in humans, and has been
well documented to detect differences in vascular responsiveness following interventions
in healthy and diseased individuals (Maiorana et al., 2001a; Modena et al., 2002; Walsh et
al., 2003; Green et al., 2006; Currie et al., 2012). Nonetheless, FMD is dependent upon
the use of high cost equipment, skilled personnel required for data acquisition, and limited
by a high coefficient of variation upon repeated measures (Hijmering et al., 2001; McLay
et al., 2016a).
Recently, near-infrared spectroscopy (NIRS) in combination with vascular
occlusion testing (VOT) has emerged as an easily applicable, non-invasive measure of
tissue oxygenation (Gerovasili et al., 2010). Immediately following an ischemic challenge,
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the NIRS-derived tissue oxygen saturation signal (StO2) rapidly increases. This dynamic
adjustment of the StO2, or the reperfusion slope, has been shown to significantly correlate
to the ultrasound-derived measure of FMD (McLay et al., 2016a). The relationship
between FMD (macrovascular responsiveness) and NIRS-derived reperfusion slope
(microvascular responsiveness) likely arises from a shared vasodilatory pathway.
However, while the FMD response to ischemia may be largely attributed to a single dilatory
pathway (i.e., endothelium-dependent vasodilation), the mechanisms governing the control
of microvascular blood flow distribution, as assessed by the reperfusion slope of StO2, are
not fully understood and there are multiple different mechanisms influencing the
microvascular response. Through the employment of NIRS and VOT, previous studies
have thus differentiated patient outcome, mortality, and response to pharmacological
intervention in vascular disease-states based on patient StO2 reperfusion rate (Creteur et
al., 2007; Doerschug et al., 2007; Nanas et al., 2008; Skarda et al., 2007).
Given the complexities of data analysis associated with FMD testing, a
standardized occlusion duration of five minutes is recommended for the measurement of
FMD, in order to observe the greatest endothelial-dependent dilatory response (Thijssen et
al., 2011a). Although this is a logical approach, recording the highest endotheliumdependent vasodilatory response to a single occlusion time might limit the ability of
establishing differences between groups that are expected to show dissimilar vascular
responsiveness. For example, Maiorana et al. (Maiorana et al., 2001b) were unable to
detect differences between a trained and untrained group of middle-aged subjects.
Metabolite build-up (including nitric oxide, ATP, and prostaglandins) is known to
influence the vascular responsiveness (Joannides et al., 1995; Toth et al., 2007; Kooijman
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et al., 2008; Crecelius et al., 2011) and it is possible that the 5 minute occlusion duration
may elicit a maximal dilatory response in all individuals. Therefore, a single long duration
occlusion period may not best reflect vascular differences between different subject
populations.
In opposition to this single measure approach, animal models typically assess
vascular reactivity by measuring a dose-response curve with exposure to a vasodilatory
substance such as acetylcholine (ACh). For example, Haram et al. (2006) reported an
increased sensitivity to lower doses of ACh following a single bout of exercise, as well as
after six weeks of endurance training, compared to age-matched controls. However, they
observed that at higher doses of ACh both exercised and control rats had similar
responsiveness to ACh. Thus, although individuals may have similar dilatory responses to
high levels of a stimulus, it is possible that improved sensitivity to lower doses may
highlight differences in vascular responsiveness. This concept introduced the idea that
differences in sensitivity to vasodilatory responses could be non-invasively evaluated by
monitoring changes in the slope of the StO2 reperfusion signal to different occlusion times
during vascular occlusion challenges. In this model, a “dose-response” like curve could be
built using the occlusion time as the vasodilatory stimulus.
Therefore, the purpose of this study was to determine if the NIRS-derived measure
of StO2 reperfusion slope (Slope 2 StO2) was sensitive to a range of ischemic conditions
(i.e., various occlusion durations), and to determine if differences exist between two groups
that would be expected to have different vascular responsiveness (i.e., trained and untrained
individuals). We hypothesized the reperfusion slope would progressively increase with the
increase in occlusion duration, and that there would be differences in the reperfusion rate
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of trained and untrained individuals, such that trained individuals were more sensitive to
shorter occlusion durations.
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Methods
Participants
Nine healthy young trained (T, mean ± SD, age: 25 ± 3 yr) and nine healthy young
untrained (UT, mean ± SD, age: 21 ± 1 yr) men volunteered and gave written informed
consent to participate in the study. All procedures conformed to the standards set by the
latest revision of the Declaration of Helsinki and were approved by the Conjoint Health
Research Ethics Board of the University of Calgary (REB15-3117). All subjects were
normotensive (T: systolic 115 ± 13 mmHg and diastolic 71 ± 8 mmHg; UT: systolic 112 ±
6 mmHg and diastolic 72 ± 5 mmHg) and no one was taking medications that would affect
cardiorespiratory or hemodynamic responses to exercise. Subjects had no history of
cardiovascular, respiratory or musculo-skeletal diseases.
Participants were classified into two groups, trained and untrained, based on selfreported cardiovascular (CV) training and results of a ramp incremental (RI) exercise test.
All T individuals reported regular CV training over a number of years and their CV fitness
attested to their reports. It should be noted that all T individuals had a maximal oxygen
uptake (V̇O2max) greater than 55 ml∙min-1∙kg-1 (DePauw et al., 2013). Conversely, UT
individuals reported participation in some physical activities but did not participate in any
regular CV training programs or athletic training and their V̇O2max was less than 55 ml∙min1

∙kg-1.

Study Design
Participants reported to the laboratory on two separate occasions. On the first visit,
subjects performed a RI exercise test (20 W baseline for 4 min followed by a 25 W min−1
ramp) on a magnetically braked cycle ergometer (Velotron RacerMate Inc., Seattle, WA,
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USA) for determination of V̇O2max. The V̇O2max was defined as the greatest 20 s pulmonary
V̇O2 computed from a rolling average, and peak power output (POpeak) was defined as the
PO achieved at termination of the RI test.
Participants returned to the laboratory on a separate day and a series of VOTs were
performed with different occlusion durations; 30 s, 1 min, 2 min, 3 min and 5 min. All
VOTs were performed on the same day and participants were instructed to refrain from
caffeine, alcohol and exercise for >12 hours prior to their scheduled visit. Prior to the
VOTs, adipose tissue thickness (ATT) was measured over the belly of the tibialis anterior
(TA) muscle in each participant. Following ATT measurements, subjects were instructed
lie down for at least 10 minutes of supine rest, the NIRS probe was secured on the tibialis
anterior muscle and a pneumatic cuff (Flexiport; Welch Allyn Inc., Skaneateles Falls, NY,
USA) was placed around the calf (proximal to the NIRS probe). For each VOT the cuff
was inflated to an occlusion pressure of 250 mmHg for the specified occlusion duration.
The order of the tests was randomized between subjects and each test was separated by a
30 minute rest period to allow blood flow to return to resting conditions.
Near-infrared spectroscopy
StO2 of the tibialis anterior muscle was monitored continuously throughout each
VOT test with a frequency-domain multidistance NIRS system (Oxiplex TS, ISS,
Champaign, Ill., USA). Briefly, the system was composed of a single channel consisting
of 8 laser diodes operating at 2 wavelengths (λ = 690 and 828 nm, 4 at each wavelength),
which were pulsed in rapid succession, and a photomultiplier tube. The lightweight plastic
NIRS probe (connected to laser diodes and a photomultiplier tube by optical fibers)
consisted of 2 parallel rows of light emitter fibers and 1 detector fiber bundle; the source-
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detector separations for this probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. The
probe was placed on the belly of the TA muscle, was secured in place with an elastic strap
tightened to prevent movement and was covered with an optically dense, black vinyl sheet,
thus minimizing the intrusion of extraneous light. An elastic bandage was applied to
further minimize intrusion of extraneous light and probe movement. The elastic strap and
bandage were tightened just enough to secure the NIRS probe in place, such that there
would be no pressure to disrupt perfusion in the area of interrogation. By measuring
changes in light absorption at different wavelengths, changes in oxyhemoglobin (HbO2)
and deoxyhemoglobin (HHb) can be measured continuously, and StO2 can be calculated
(defined as [HbO2] / [HbO2 + HHb]). NIRS measurements were collected continuously
for the entire duration of each VOT test (2 min baseline, pre-determined occlusion duration
and 8 min post-release).
The NIRS device was calibrated at the beginning of the first test session following
an instrument warm-up period of at least 20 min. The calibration was done with the probe
placed on a calibration block (phantom) with absorption (μa) and reduced scattering
coefficients (μs’) previously measured; thus, correction factors were determined and were
automatically implemented by the manufacturer’s software for the calculation of the μa and
μs’ for each wavelength during the data collection. Calculation of [HbO2] and [HHb]
reflected continuous measurements of μs’ made throughout each testing session (i.e.,
constant scattering value not assumed). The probe remained secured to the leg throughout
the duration of the visit to ensure measurement consistency between all tests. Data were
stored online at an output frequency of 2 Hz, sampling every 0.5 s, but were reduced to 1 s
time bins for all subsequent analyses within the present study to facilitate noise reduction.
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Baseline StO2 (% a.u.) was calculated as the average of 1 min of StO2 prior to
ischemia. Minimum StO2 (% a.u.) was calculated as the lowest StO2 value attained during
ischemia. The StO2 reperfusion rate was quantified as the upslope of the StO2 signal (Slope
2 StO2, % a.u.∙s-1) during a 10 second window immediately following cuff release. It
should be noted that immediately after cuff release there is a linear increase in the StO 2,
followed by a brief plateau around the Peak StO2. This linear response is sustained for
greater than 10 seconds which allows for an accurate slope to be easily calculated when
including the initial reperfusion phase immediately following cuff release. Peak StO2 (%
a.u.) was calculated as the highest StO2 value reached following cuff release (McLay et al.,
2016a). The ‘metabolic accumulation’ for each occlusion duration was determined as the
integrated area under the curve (AUC) (Origin, OriginLab Corp., Northampton,
Massachusetts, USA) during the occlusion period, taken from cuff inflation to cuff release.
For a schematic representation of each parameter see Figure 1.
Statistical Analysis
All statistical analyses were performed using SPSS software, version 23.0 (SPSS
Inc., Chicago, Ill., USA) and Microsoft Excel 2010 (Microsoft, Seattle, Wash., USA). All
results are presented as means ± standard deviation (SD). The estimates for the NIRSderived parameters were analyzed with a two-way analysis of variance (ANOVA) for
repeated measures. Significant interactions and main effects were analyzed using a LSD
post hoc test. Pearson product–moment correlation coefficient was used to determine
relationship of occlusion AUC and Slope 2 StO2. Statistical significance was accepted at
P < 0.05.
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Results
Subject characteristics for both groups are listed in Table 5.1. Those in the T group
all had a V̇O2max exceeding 55 ml∙min-1∙kg-1 with a mean of 63.4 ml∙min-1∙kg-1 (range: 57.8
to 76.5 ml∙min-1∙kg-1), whereas the untrained group averaged 46.6 ml∙min-1∙kg-1 (range:
42.8 to 50.1 ml∙min-1∙kg-1) with all individuals below 55 ml∙min-1∙kg-1.
The StO2 profiles for trained and untrained group mean data are depicted in Figure
1; which also illustrates the NIRS parameters calculated for each VOT. Group mean and
SD for StO2 parameters measured for each VOT duration are listed in Table 2 for both
groups. Slope 2 StO2 was significantly steeper in T compared to UT (P = 0.01) at all
occlusion durations.

Slope 2 StO2 was progressively steeper as the occlusion time

increased (Figure 2, P < 0.001), indicating greater vascular reactivity during longer
occlusion times, however there was a significant interaction effect (P = 0.01). For the
trained group the slope 2 StO2 at 30 s was significantly less steep than at 1 min, 2 min, 3
min and 5 min (P < 0.001, P < 0.001, P < 0.001 and P < 0.001, respectively). Similarly,
slope 2 StO2 at 1 min was less steep than all other longer durations (2 min, P < 0.001; 3
min, P < 0.01; 5 min, P < 0.001). Slope 2 StO2 following 2 min occlusion was similar to 3
min (P = 0.92); however, they both were less steep than following 5 min of occlusion (2
min, P < 0.01; 3 min, P = 0.01). For the untrained group, slope 2 StO2 at 30 s was smaller
than at 1 min, 2 min, 3 min and 5 min (P = 0.02, P = 0.01, P = 0.01 and P = 0.02,
respectively). One minute of occlusion resulted in a slope 2 StO2 that was significantly
less steep than following 2 min and 3 min (P = 0.04 and P = 0.03, respectively), albeit not
different from 5 min (P = 0.07).
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Baseline StO2 was not different between groups (P = 0.14) or occlusion durations
(P = 0.49) (Table 2). AUC during the occlusion period was progressively larger as the
occlusion duration increased (P < 0.001) and although there was no difference between
groups (P = 0.05), there was a trend for occlusion AUC to be larger in T compared to UT
(Figure 3). Min StO2 was significantly lower in T compared to UT (P = 0.01) at all
occlusion times, and Min StO2 significantly decreased as occlusion duration increased (P
< 0.001) (Table 2). Peak StO2 was similar between groups (P = 0.78) with no difference
for changes in Peak StO2 (main effect for occlusion duration (P < 0.001) with no interaction
effect (0.19)). Mean Peak StO2 was higher as the occlusion time increased, such that 30 s
was smaller than all longer occlusion times (Table 2, P < 0.001). Similarly, Peak StO 2
following 1 min and 2 min of occlusion was significantly smaller than following 3 min (P
< 0.001 and P = 0.04, respectively) and 5 min of occlusion (Table 2; P < 0.001 and P =
0.01, respectively).
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Table 5.1. Subject characteristics and peak exercise responses.
#

Untrained (n = 9)
21 ± 1
74 ± 9
183 ± 9
46.6 ± 2.5
340 ± 45
112 ± 6
72 ± 5
8.6 ± 2.0

Age (yr)
Weight (kg)
Height (cm)
Relative VO2max (ml∙kg-1∙min-1)#
Peak Power Output (W)#
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Adipose Tissue Thickness (mm)
Values are means ± standard deviations.
#
Significant (P < 0.05) difference between groups
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Trained (n = 9)
25 ± 3
76 ± 5
180 ± 4
63.4 ± 5.6
414 ± 30
114 ± 12
71 ± 8
7.4 ± 0.8

Table 5.2. Average parameter estimates for StO2 following different durations of vascular occlusions.
Trained

Untrained

BSLN StO2 (% a.u.)

30 s
68.0 ± 3.3

1 min
69.5 ±2.3

2 min
68.8 ± 3.1

3 min
68.5 ± 2.8

5 min
68.4 ± 3.5

Min StO2 (% a.u.)

60.9 ± 2.7

57.0 ± 3.5*

48.1 ± 5.2*†

42.4 ± 4.5*†‡

34.3 ± 5.0*†‡§

Peak StO2 (% a.u.)

74.6 ± 2.0

78.1 ± 1.8*

80.4 ± 2.7*

81.2 ± 3.0*†‡

81.9 ± 1.4*†‡

Slope 2 StO2 (% a.u.∙s-1)

1.11 ± 0.29

1.63 ± 0.30*

2.34 ± 0.33*†

2.33 ± 0.37*†

2.83 ± 0.48*†‡§

Occlusion AUC (% a.u.∙s)

54.8 ± 35.9

267.8 ± 118.8*

889.2 ± 116.6*†

1817.4 ± 196.5*†‡

4305.4 ± 530.2*†‡§

BSLN StO2 (% a.u.)

71.1 ± 4.2

71.9 ± 4.6

70.7 ± 3.2

71.9 ± 4.4

71.7 ± 4.0

#

67.7 ± 3.6

64.9 ± 3.5

*

Peak StO2 (% a.u.)

75.9 ± 3.3

77.3 ± 4.1*

Slope 2 StO2 (% a.u.∙s-1)#

0.61 ± 0.19

Occlusion AUC (% a.u.∙s)

62.5 ± 49.4

Min StO2 (% a.u.)

56.4 ± 4.4

*†‡

50.0 ± 5.2*†‡§

77.9 ± 4.3*

80.2 ± 3.2*†‡

79.9 ± 2.8*†‡

0.84 ± 0.19*

1.15 ± 0.31*†

1.21 ± 0.30*†

1.26 ± 0.28*

198.0 ± 61.5*

702.6 ± 200.1*†

1463.7 ± 374.1*†‡

3474.0 ± 715.3*†‡§

59.5 ± 3.9

*†

Values are means ± SD.
#
Significant (P < 0.05) difference between groups at all occlusion durations.
*
Significant (P < 0.05) difference from 30 s.
†
Significant (P < 0.05) difference from 1 min.
‡
Significant (P < 0.05) difference from 2 min.
§
Significant (P < 0.05) difference from 3 min.
62.5 ± 49.4

198.0 ± 61.5*

702.6 ± 200.1*†

1463.7 ± 374.1*†‡
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3474.0 ± 715.3*†‡§

Figure 5.1. NIRS-derived profiles of % tissue oxygen saturation (StO2) measured during
a 5 minute vascular occlusion test for one trained (black line) and one untrained (grey line)
representative subject. NIRS parameters are marked up on the trained subject’s profile to
illustrate what was calculated for each participant. Slope 2 StO2 for the trained subject
shown here was 2.06 % a.u.∙s-1 and for the untrained subject was 1.14 % a.u.∙s-1 following
the 5 min occlusion duration.
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Figure 5.2. Trend of Slope 2 StO2 following different durations of vascular occlusion.
#

Significant (P < 0.05) difference between groups at all occlusion durations; * Significant

(P < 0.05) difference from 30 s; † Significant (P < 0.05) difference from 1 min; ‡ Significant
(P < 0.05) difference from 2 min; § Significant (P < 0.05) difference from 3 min.
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Figure 5.3. Group mean occlusion area under the curve (AUC) for trained (black open
circles) and untrained (grey open squares) groups following each occlusion duration.
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Discussion
This study used a novel approach to non-invasively evaluate vascular
responsiveness by examining the sensitivity of the StO2 reperfusion slope across a range
of occlusion durations, and examined if differences in vasodilatory responses between
trained and untrained individuals could be determined using this approach. The main
findings were: (i) Slope 2 StO2 was sensitive to different occlusion durations, such that the
Slope 2 StO2 was progressively steeper with the increase in occlusion duration; (ii) trained
individuals had a steeper Slope 2 StO2 compared to untrained following all occlusion
durations, supporting the notion that NIRS-derived measures of StO2 can be used to detect
differences in vascular responsiveness between groups.
A major finding of the present study was that the reperfusion slope, which has been
shown to positively correlate to FMD (McLay et al., 2016a) and to reflect vascular
reactivity, was sensitive to various ischemic conditions, such that the longer occlusion
durations resulted in the steepest reperfusion slopes. This behavior was present in both
groups, however the present data indicate that trained individuals were more responsive to
progressively larger stimuli such that significant differences were more noticeable at a
wider range of occlusion durations. This sensitivity of the reperfusion slope of the StO 2
measure may have important implications for assessing vascular responsiveness not only
for group comparisons, but also within an individual. For example, the longer occlusion
time typically used in FMD measurements or previously proposed for the slope 2 StO2
analysis (McLay et al., 2016a), may result in a stimulus that will produce the largest level
of vascular responsiveness. This high level of stimulus may challenge the ability to detect
changes following an intervention-type study in some particular populations. Additionally,
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even if differences at the highest level of stimulus already exist, there are situations in
which analysis at lower levels of stimulus provide valuable information from a vascular
responsiveness perspective. For example, in older and/or diseased populations it could be
that examining a “dose-response” like profile would provide a more detailed analysis that
would inform about differences that occur at a variety of levels of stimulus (i.e., level of
ischemia), that could be analogous to different intensities of exercise. In this context, an
increased vascular responsiveness at a lower stimulus could have important functional
implications, as people often perform activities of daily living at lower relative intensities
of exercise. This practice of measuring a “dose-response” to a vasodilatory stimulus has
been well-established in animal models to assess vascular reactivity (Ulker et al., 2003;
Muller-Delp, 2006; Rodrigues et al., 2008). For example, Haram et al. (Haram et al., 2006)
found that exercise training in healthy rats resulted in an increased sensitivity to lower
doses of ACh; however, at higher [ACh] there appeared to be no differences in
endothelium-dependent vasodilation between trained and untrained rats. The data from the
present study mimics those from these animal models such that the reperfusion slope is
sensitive to lower “doses” of ischemia and provides a novel non-invasive and more
comprehensive way of estimating vascular responsiveness in humans.
Another important finding of the present study was that the reperfusion slope is not
only sensitive to different occlusion durations, but that differences between groups can be
detected with this technique. This study showed that the Slope 2 StO2 was significantly
steeper in the trained group compared to the untrained group across all occlusion durations,
such that for a given ischemic challenge (occlusion duration) trained individuals were more
responsive compared to untrained. Vascular reactivity has been commonly measured by
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FMD and it has been well established through previous studies that exercise training
improves endothelial function (Rakobowchuk et al., 2008; Tinken et al., 2008; Black et
al., 2009; Thijssen et al., 2011b; Currie et al., 2012). Additionally, FMD has been shown
to differentiate between clinical populations and healthy controls (Maiorana et al., 2001a;
Modena et al., 2002; Walsh et al., 2003; Green et al., 2006; Currie et al., 2012); however,
some studies using FMD have failed to find differences in groups that were expected to
show them. Using the reperfusion slope, or Slope 2 StO2, which has been shown to
correlate with FMD responses (McLay et al., 2016a), group changes in vascular
responsiveness might be easier to detect in the sense that differences can be established
across a wide range of stimuli. The present study is the first to show that non-invasive
NIRS-derived measures of StO2, specifically the reperfusion rate, can be used to detect
differences in vascular responsiveness between two groups that are expected to differ in
this response.
The present data also suggest that this “dose-response” like approach may be
sensitive to detect more subtle differences in vascular health that might occur in other
populations. Constructing a dose-response curve is commonly employed in animal studies
examining vascular responsiveness, for example, in response to vasodilatory substances
such as ACh (Ulker et al., 2003; Muller-Delp, 2006; Haram et al., 2006; Rodrigues et al.,
2008). This provides insight into the extent of vasodilation to a given dose, but also the
sensitivity to different levels of stimuli. Although there was a significant difference
between groups at each occlusion duration in the present study, indicating that a single
vascular occlusion may be sufficient to identify differences between these two groups, this
may not be the case between different populations. It is possible that in other populations
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changes might be small and only detectable at 1 or 2 of the occlusion times, eliciting a left(or right-) shift in the curve. For example, the effects of a short-term exercise training
intervention might not be apparent, or might not trigger the changes with longer occlusion
durations, however differences might appear with the shorter occlusion durations. In other
words, even though it was not evident in the present study, building a “dose-response” like
curve for measurement of vascular responsiveness at different levels of stimuli should
facilitate detection of changes in vascular reactivity that might be missed otherwise. This
is important as the FMD technique, which is widely used for estimating vascular
responsiveness in humans, uses a single occlusion duration as the technique is associated
with challenges such as high cost of equipment, technical skill and time for analysis. In
opposition to this, NIRS measures have been shown to be repeatable (Gómez et al., 2008;
McLay et al., 2016b), the equipment is easy to operate and the subsequent data analysis is
simple such that assessments of vascular responsiveness can be rapidly obtained.
The present study reported that AUC during the occlusion period increased with
the lengthening of occlusion duration and that, although there was no significant difference
between groups, there was a trend toward significance such that the trained group may have
a greater occlusion AUC. The desaturation rate, or in the case of the present study the
occlusion period AUC, has been indicated to represent metabolic accumulation during
ischemia (De Blasi et al., 1994), such that greater accumulation of metabolites is thought
to result in a more rapid rate of reperfusion, or Slope 2 StO2. In the present study it appears
that multiple mechanisms play a role in the reperfusion response of StO2.

The

microvascular responsiveness, as assessed by StO2 reperfusion rate, is at least in part reliant
on metabolic mechanisms of vascular control; however, there are likely other mechanisms
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related to endothelial-dependent dilation that are also contributing to this response and the
combination of mechanisms is ultimately reflected by upstream vasodilation, typically
measured by FMD. In contrast, the FMD response (macrovascular responsiveness) being
measured proximal to the site of occlusion is thought to be largely reliant on a single
vasodilatory pathway, endothelium-dependent nitric oxide-mediated vasodilation.
In the present study NIRS-derived parameters were not normalized for ATT, as the
saturation signal is calculated as a ratio that is independent of absolute amplitudes that are
influenced by ATT (Koga et al., 2011). However, while ATT has been shown to influence
the absolute measurement values obtained for the oxy- and deoxyhemoglobin
concentrations it has been suggested that dynamic changes should be unaffected as the
changes are independent of absolute values (Bopp et al., 2011). That being said, the TA
muscle offers an ideal sight of measurement for NIRS as there is often less adipose tissue
overlying the muscle compared to other muscles in the leg. Choosing a muscle in the leg
was an important factor when selecting the area of NIRS interrogation as several training
studies are predominately lower limb exercises (such as cycling and running) and thus, it
is important to be able to assess vascular responsiveness in the region that is more affected
by the proposed intervention. In addition to measuring vascular reactivity in the leg, NIRS
allows for assessment of responsiveness of smaller vessels at a level of the microcirculation
within the muscle. FMD is assessing vascular function of conduit arteries and this provides
a challenge, particularly with the larger vessels in the leg compared to the more commonly
assessed vessels of the arm. More specifically, the relatively small changes in conduit
artery diameter following a 5 min occlusion in comparison to the large vessel diameters
can affect the calculation of FMD, such that differences in vascular function can be
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undetectable with this technique (Maiorana et al., 2001b). Although measuring StO2 in
other muscles of the leg such as the quadriceps would also be valuable, the occlusion
pressure required to fully occlude blood flow through the upper thigh would often need to
be higher and may be associated with more discomfort for individuals. Occlusion of the
lower leg is more easily achieved, while the TA muscle can also be easily isolated from
other muscles in the area which allows for a greater level of confidence in which vascular
bed is being measured. It is important to note that in some instances changes in skin blood
flow may also influence the NIRS-derived StO2, however that would not be the case with
the NIRS system used in the present study (Koga et al., 2014), but should be considered
for future applications. Additionally, the exchange of oxygen across muscle capillary beds
is facilitated by increases in both blood velocity and increasing microvascular blood
volume through greater capillary perfusion. The NIRS-derived StO2 is measuring a
combination of these two factors which both contribute to the reperfusion rate of the StO 2
response. In the future, the use of dynamic quantitative contrast-enhanced ultrasound in
combination with NIRS, may provide insight into differentiating between blood velocity
and blood volume through high resolution imaging of blood perfusion of the muscle.
In conclusion, the present study demonstrated that the reperfusion rate of StO2 is
sensitive to different occlusion durations, and that the changes in the sensitivity of the StO2
measure to a variety of ischemic challenges can be used to detect differences between two
groups (i.e., trained and untrained). These data support the notion that NIRS-derived
measures of StO2, specifically the reperfusion slope following a vascular occlusion, can be
used as a measure of vascular responsiveness.
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CHAPTER VI: General Discussion and Conclusions

Cardiovascular disease (CVD) is presently the leading cause of morbidity and
mortality in industrialized societies and changes in vascular function at both the macroand micro-vascular level have been proposed as precursors to CVD (Lloyd-Jones et al.,
2010). Therefore, it is important to have a means to accurately and non-invasively assess
vascular responsiveness to facilitate early detection of impairments, or track changes with
interventions (i.e., lifestyle, pharmacological, etc.). Presently, the most widely used
technique to assess endothelial dysfunction is the Doppler ultrasound measure of flowmediated dilation (FMD). This method allows for non-invasive imaging of a conduit artery
and is used to monitor changes in diameter following a hyperemic response to ischemia.
Although this measure is widely used, it is technically challenging to perform, analyze and
in some cases interpret. Additionally, while the FMD technique may provide insight into
the endothelial function of a conduit artery, the vascular responsiveness of downstream
vessels responsible for perfusion of tissues remains unclear. This thesis explored new
strategies to non-invasively determine the magnitude and dynamic adjustment of vascular
responses in humans.

Summary of Studies
The studies comprising this thesis relied on two non-invasive techniques. The first,
the FMD technique, involves continuous Doppler ultrasound imaging of a conduit artery
to measure changes in vessel diameter following 5 min of distal arterial occlusion. The
reactive hyperemia subsequent to ischemia results in a flow-mediated dilatory response
which can be quantified as the greatest percent change in diameter (%FMD). The second
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technique involves the continuous measurement of tissue oxygen saturation (StO2), via
near-infrared spectroscopy (NIRS), before, during and after proximal arterial occlusion.
While the FMD technique has been widely used in diverse populations, the newly emerging
NIRS-derived measure of StO2 has only been applied to clinical populations for
measurement of small tissue areas (i.e., thenar eminence). It remained unclear whether this
technique could be applied to the larger muscles of the leg, or in healthy populations to
assess vascular responsiveness, and to detect more subtle differences in vascular function.
In Chapter II the aim was to compare the more recently developed NIRS-derived
measure of vascular reactivity to that of the widely used ultrasound-derived FMD
technique.

StO2 over the tibialis anterior (TA) muscle was continuously measured

throughout a vascular occlusion test (VOT). While several parameters can be measured,
we focused on the reperfusion rate of saturation (Slope 2 StO2) following 5 min of vascular
occlusion of the popliteal artery to evaluate if a correlation could be established with FMD.
We were able to establish a significant correlation between the NIRS-derived measure of
Slope 2 StO2 and the ultrasound-derived measure of %FMD. These data supported the
notion that NIRS-derived measures of StO2, specifically Slope 2 StO2, obtained directly at
the microvascular level were reflective of the vascular responsiveness as measured by
FMD.
After establishing the correlation between the NIRS-derived reperfusion rate and
the currently used measure of vascular function, %FMD, it was important to establish the
reliability of the new technique. Therefore, Chapter III examined the test-to-test (intraday)
and day-to-day (interday) reliability of the Slope 2 StO2. As the FMD technique is
presently the most widely used measure of vascular function we compared the reliability
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of Slope 2 StO2 to that of %FMD. We found that the Slope 2 StO2 measure had strong
reliability both within and between testing days, which was in fact markedly better than
that of %FMD. These data suggested that the strong reliability, both intra- and interday,
of the NIRS-derived Slope 2 StO2 measure would make this technique a more suitable one
for the assessment of vascular responsiveness, as it might contribute in determining
differences between groups or before and after an intervention that would be otherwise
difficult to establish.
Although the measure of %FMD is widely used, limitations have been
acknowledged such as poor reliability, as shown in Chapter III, and bias towards baseline
diameter (Dbase). In regard to the latter, the Dbase of the vessel is proposed to influence the
calculation of %FMD (as traditional FMD is calculated as the change in diameter relative
to Dbase); such that individuals with a larger Dbase will have a smaller %FMD for a given
change in diameter compared to someone with a smaller Dbase. In this regard, Atkinson et
al. (2013) proposed the use of allometric scaling of FMD to eliminate the dependency of
%FMD on Dbase. These authors proposed the use of an ANCOVA model to generate
‘corrected’ group mean values for %FMD and also outlined a new calculation for scaling
individual %FMD values (Atkinson scaling FMD). Using our data, preliminary analysis
of individual values for Atkinson scaling FMD resulted in values that were substantially
different from the ‘corrected’ group mean values, as well as the original values, and were
not physiologically meaningful based on previously reported data. Chapter IV examined
if the employment of a new approach (New scaling FMD) to allometrically scale values for
FMD could improve the ability to obtain individual values that were corrected for
variations in baseline diameter between subjects. Results demonstrated that the average
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from individual values derived from the Atkinson scaling FMD calculation were 3-4 fold
larger than meaningful %FMD values that were to be expected. Unfortunately, while the
new scaling calculation for FMD resulted in values that were within the expected %FMD
response for this measure, it did not correct for variation in Dbase as well as the Atkinson
scaling FMD calculation. These results demonstrated that while allometric scaling offers
some benefits in that it reduces the bias of Dbase on the FMD measurement, individual
values cannot be calculated. This reduces the prognostic value of the measure and limits
the ability to examine its repeatability. Finally, these data showed no advantage of
employing the allometric scaling approach in a relatively homogenous population of
healthy young individuals. Thus, recommendations related to the advantages of scaling
%FMD in similar sample groups should be interpreted with caution until the benefits can
clearly be established.
With limitations of the FMD technique being addressed in Chapters III and IV,
Chapter II and III established and evaluated the reliability of a new approach to noninvasively assess vascular reactivity with the use of NIRS. The VOT used in Chapters II
and III was for a fixed duration, as a standardized occlusion duration of 5 minutes is
recommended for the measurement of FMD. Chapter V explored the idea that differences
in sensitivity to vasodilatory responses could be non-invasively evaluated by monitoring
changes in the reperfusion rate following different occlusion durations during VOT. This
“dose-response” like curve could be built using occlusion duration as the vasodilatory
stimulus. An additional aim of the study in Chapter V was to determine if differences
existed between two groups that would be expected to have different vascular
responsiveness (i.e., trained and untrained individuals). Results demonstrated that a “dose-
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response” like curve can be constructed, as Slope 2 StO2 was sensitive to changes with the
increase in occlusion duration. Additionally, trained individuals had a steeper Slope 2 StO2
compared to untrained individuals following each of the occlusion durations. These data
demonstrated that the reperfusion rate, Slope 2 StO2, is sensitive to different occlusion
durations, and that these changes in the sensitivity of the measure to a variety of ischemic
challenges can be used to detect differences between two groups (i.e., trained and
untrained).
In summary, this series of studies explored new strategies to non-invasively
determine vascular responsiveness in humans.

While the ultrasound-derived FMD

technique is currently the most widely used measure of vascular function, NIRS-derived
measures of StO2 can be easily obtained and correlate to %FMD. The reperfusion rate,
Slope 2 StO2, of the StO2 signal throughout a VOT can be used as a measure of vascular
responsiveness and is a reliable measure both within and between days. This measure of
Slope 2 StO2 is sensitive to different occlusion durations and changes in this sensitivity can
be used to detect group differences in vascular reactivity. Therefore, NIRS-derived
measures of StO2 show promise for assessing vascular responsiveness between groups, or
for monitoring changes in vascular responses to various interventions (i.e., training, diet or
pharmacological).

Assumptions and Limitations
The studies comprising this thesis used non-invasive means to assess vascular
responsiveness in humans and, as with most non-invasive measures, the interpretation of
these data were based on several assumptions:
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First, the ultrasound-derived measure of %FMD is based on the assumption that
increases in blood flow following a brief period of ischemia elicit a shear stress force on
the endothelial cells lining the conduit artery being insonated. This shear stress force
causes a resultant dilatory response that is thought to be primarily nitric oxide (NO)
mediated. Studies that infused NO blockades upstream from an insonation sight reported
that dilatory responses to ischemia and shear stress were almost or completely abolished
(Joannides et al., 1995; Mullen et al., 2001; Doshi et al., 2001). However, it is important
to note that not all studies have been able to inhibit the FMD response using NO blockades
(Pyke et al., 2009). A recent meta-analysis of literature examining the contribution of NO
in FMD of conduit arteries revealed that with the current standardized technique of FMD
~72% of the dilatory response is mediated by NO, with the remainder of the FMD response
being influenced by the role of other vasoactive substances (Green et al., 2014).
Additionally, while the FMD technique assesses conduit endothelial function pathways
stimulated by shear stress, some interventions, such as exercise training, may induce
changes in many signaling pathways and vasodilator mechanisms other than those induced
by FMD which might make isolating any one pathway is difficult.
Secondly, the NIRS-derived StO2 reperfusion rate as a measure of vascular
responsiveness was evaluated against another non-invasive measure, the FMD technique.
The FMD technique is widely accepted as an index of vascular function and has been
shown to closely relate with coronary vasomotor response to infusion of dilatory substances
(Anderson et al., 1995; Takase et al., 1998b). However, the ideal validation of the NIRS
technique would be to assess vasodilatory responses to intra-arterial infusion of a
vasoactive substance such as acetylcholine (ACh). The dilatory response to infused ACh
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can be assessed in peripheral vessels by strain-gauge plethysmography. Although this
invasive measure is associated with fewer risks than the assessment of endothelial function
in coronary arteries by coronary angiography, the invasive nature of the measure prevented
its applicability in the studies comprising this thesis. Comparison of the StO 2 reperfusion
rate with different ACh infusion across a range of doses would provide further validation
to this newly developed non-invasive measure.
Thirdly, there are various limitations associated with NIRS for the determination of
StO2. Near-infrared light has the capacity to penetrate skin and bone and reach muscle
tissue. In the tissue, light is absorbed by chromophore molecules, the most important of
which is hemoglobin.

As discussed previously, absorption characteristics of

deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2) differ. When light of different
wavelengths is emitted through muscle tissue, it is absorbed to different degrees depending
on the relative concentrations of HHb and HbO2. With the use of scattering and absorption
coefficients in combination with the modified Beer-Lambert law, saturation of the
microvasculature of the respective tissue can be calculated. However, before the NIR light
reaches the muscle tissue it must first pass through different layers, such as the epidermis
and dermis. Within these layers chromophores are present which can cause light absorption
independent of Hb saturation such as melanin, bilirubin and cytochrome c oxidase (Madsen
& Secher, 1999). Within the muscle tissue itself another chromophore, myoglobin (Mb),
is present (Ferrari et al., 2004). Therefore the absorption calculated by the NIRS system
may not be solely reflecting that of HHb and HbO2. Additionally, the models used to
quantify Hb concentrations can only approximate the amount of scattered NIR light. The
models used do not predict nonlinear paths of light, which are likely to be present in human
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tissue (Hiraoka et al., 1993). It is also important to note that the NIRS-derived StO2 is an
average of the saturation of hemoglobin in all vascular compartments (including arterioles,
capillaries and venuoles) within the tissue. Additionally, NIRS-derived measures of tissue
oxygen saturation are made over a small region of the TA muscle. This places a heavy
reliance on that small area of NIRS “interrogation” to be reflective of different portions of
the muscle, however it has been shown in other muscle groups that this may not be the case
(Koga et al., 2007).

Future Directions
Chapter II established that a significant correlation exists between NIRS-derived
Slope 2 StO2 and %FMD indicating that Slope 2 StO2 can be used as a measure of vascular
responsiveness. As mentioned previously, the FMD technique is a non-invasive measure
that is assumed to reflect endothelial function of central and peripheral vasculature.
However, future studies should look toward evaluating the non-invasive NIRS-derived
measure of StO2 against the gold standard for assessing endothelial function, intra-arterial
infusion of ACh. This line of research could be particularly valuable with regard to the
“dose-response” like approach to assessing vascular reactivity developed in Chapter V of
this thesis. Additionally, the administration of pharmacological vasodilatory agents and
blockades (for example NG-monomethyl-L-arginine (L-NMMA); a common NO blockade)
in combination with the measurement of StO2 throughout a vascular occlusion test may be
beneficial in elucidating the governing mechanisms of microvascular responsiveness.
While Chapter V established that the differences in the NIRS-derived Slope 2 StO2,
a measure of vascular responsiveness, can be used to detect differences in vascular
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reactivity between two groups, these findings should be further substantiated. In Chapter
V, it was demonstrated that healthy young trained individuals have a significantly greater
rate of reperfusion immediately following ischemia across a range of occlusion durations.
However, it remains unclear whether differences in vascular reactivity between other
groups can be detected with this technique. Future studies need to examine the reperfusion
rate, Slope 2 StO2, in a diverse group of individuals across the lifespan. It has been shown
that endothelial function declines with age (Muller-Delp et al., 2002; Parker et al., 2006;
Black et al., 2009) and therefore it would be of interest to compare healthy young, middleaged and older adults. Additionally, it was discussed earlier in this thesis that bedside
measures of StO2 and the reperfusion rate have been previously examined in clinical
populations suffering from severe sepsis and septic shock. It would be interesting to apply
this technique to assess vascular reactivity in other clinical populations with more
hemodynamically stable conditions but where impaired vascular reactivity may still be
present (i.e., diabetes, peripheral artery disease, etc.). Finally, the influence of sex on this
measure remains to be ascertained. The studies comprising this thesis all examined this
measure of vascular reactivity in young men. As sex hormones, and fluctuations of
hormones in women, are known to impact endothelial function (Huang et al., 1998; Pak et
al., 2002; Black et al., 2009), then differences in vascular responsiveness would be
expected. Future studies need to examine both men and women and consider that the
vascular reactivity for the two sexes may be different. With further research, it may be
possible to establish if sex-related differences exist, and if so, to characterize the wide
spectrum of vascular reactivity for each group to provide references for clinical relevance.

123

In addition to the cross-sectional approach to comparing the vascular reactivity of
different groups detailed above, it would also be of value to track differences in any or all
of the groups throughout an intervention, like exercise training. Although Chapter V
showed significant differences in the reperfusion rate (i.e., Slope 2 StO2) between two
groups with markedly different cardiovascular fitness levels, it has yet to be established if
this approach to assessing vascular reactivity can be used to track changes in an individual.

124

References
Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH,
Ganz P, Creager MA, Yeung AC & Selwyn AP (1995). Close relation of endothelial
function in the human coronary and peripheral circulations. J Am Coll Cardiol 26,
1235–1241.
Atkinson G, Batterham AM, Thijssen DHJ & Green DJ (2013). A new approach to improve
the specificity of flow-mediated dilation for indicating endothelial function in
cardiovascular research. J Hypertens 31, 287–291.
Black MA, Cable NT, Thijssen DHJ & Green DJ (2009). Impact of age, sex, and exercise
on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 297,
H1109–H1116.
Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ & Goodfellow J (2001).
Flow-mediated dilatation following wrist and upper arm occlusion in humans: the
contribution of nitric oxide. Clin Sci (Lond) 101, 629–635.
Ferrari M, Mottola L & Quaresima V (2004). Principles, techniques, and limitations of near
infrared spectroscopy. Can J Appl Physiol = Rev Can Physiol Appl 29, 463–487.
Green DJ, Dawson EA, Groenewoud HMM, Jones H & Thijssen DHJ (2014). Is flowmediated dilation nitric oxide mediated?: A meta-analysis. Hypertension 63, 376–382.
Hiraoka M, Firbank M, Essenpreis M, Cope M, Arridge SR, van der Zee P & Delpy DT
(1993). A Monte Carlo investigation of optical path-length in inhomogenous tissue
and its application to near-infrared spectroscopy. Phys Med Biol 38, 1859–1876.
Huang A, Sun D, Koller A & Kaley G (1998). Gender difference in flow-induced dilation
and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol 275,
R1571–R1577.
Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C & Lüscher TF
(1995). Nitric oxide is responsible for flow-dependent dilatation of human peripheral
conduit arteries in vivo. Circulation 91, 1314–1319.
Koga S, Poole DC, Ferreira LF, Whipp BJ, Kondo N, Saitoh T, Ohmae E & Barstow TJ
(2007). Spatial heterogeneity of quadriceps muscle deoxygenation kinetics during
cycle exercise. J Appl Physiol (Bethesda, Md 1985) 103, 2049–2056.
Lloyd-Jones D et al. (2010). Executive summary: heart disease and stroke statistics--2010
update: a report from the American Heart Association. Circulation 121, 948–954.
Madsen PL & Secher NH (1999). Near-infrared oximetry of the brain. Prog Neurobiol 58,
541–560.
125

Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE &
MacAllister RJ (2001). Heterogenous nature of flow-mediated dilatation in human
conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.
Circ Res 88, 145–151.
Muller-Delp JM, Spier SA, Ramsey MW & Delp MD (2002). Aging impairs endotheliumdependent vasodilation in rat skeletal muscle arterioles. Am J Physiol Heart Circ
Physiol 283, H1662–H1672.
Pak KJ, Geary GG, Duckles SP & Krause DN (2002). Male-female differences in the
relative contribution of endothelial vasodilators released by rat tail artery. Life Sci 71,
1633–1642.
Parker BA, Ridout SJ & Proctor DN (2006). Age and flow-mediated dilation: a comparison
of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart
Circ Physiol 291, H3043–H3049.
Pyke K, Green DJ, Weisbrod C, Best M, Dembo L, O’Driscoll G & Tschakovsky M (2009).
Nitric oxide is not obligatory for radial artery flow-mediated dilation following release
of 5 or 10 min distal occlusion. Am J Physiol Hear Circ Physiol 298, H119–H126.
Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F &
Kurita A (1998). Endothelium-dependent flow-mediated vasodilation in coronary and
brachial arteries in suspected coronary artery disease. Am J Cardiol 82, 1535–1539,
A7–A8.

126

APPENDIX I: Ethics approvals

127

128

Conjoint Health Research Ethics Board
Research Services Office
3rd Floor MacKimmie Library Tower (MLT 300)
2500 University Drive, NW
Calgary AB T2N 1N4
Telephone: (403) 220-7990
resethic@ucalgary.ca

CERTIFICATION OF INSTITUTIONAL ETHICS REVIEW
This is to certify that the Conjoint Health Research Ethics Board at the University of
Calgary has examined the following research proposal and found the proposed
research involving human participants to be in accordance with University of Calgary
Guidelines and the Tri-Council Policy Statement: Ethical Conduct for Research
Involving Humans 2010 (TCPS 2). This form and accompanying letter constitute the
Certification of Institutional Ethics Review.
Ethics ID:

REB15-3117_MOD1

Principal Investigator:

Juan Murias

Co-Investigator(s):

There are no items to display

Student Co-Investigator(s):

James Gilbertson

Study Title:

Vascular Occlusion Duration and the NIRS-Derived
Reperfusion Rate of Tissue Oxygen Saturation in
Healthy Subjects

Sponsor (if applicable):
Effective: 1/4/2016

Expires: 1/4/2017

Restrictions:
This Certification is subject to the following conditions:
1. Approval is granted only for the project and purposes described in the
application.
2. Any modification to the authorized study must be submitted to the Chair,
Conjoint Health Research Ethics Board for approval.
3. An annual report must be submitted within 30 days prior to expiry date of this
Certification, and should provide the expected completion date for the study.
4. A final report must be sent to the Board when the project is complete or
terminated.

129

Approved By:

Date:

Stacey A. Page, PhD, Chair , CHREB

January 18, 2016

130

APPENDIX II: Letters of information and consent forms

LETTER OF INFORMATION
How reliable are repeated measures of flow-mediated
vasodilation and what are the effects of different occlusion
pressures on the flow-mediated dilatory response?
Principal Investigator: Donald H Paterson, PhD
MSc Student: Kaitlin McLay, BSc
Purpose of Study: You are being invited to participate in a research study that examines the
effects of different occlusion pressures on the flow-mediated dilation (FMD) response in the
popliteal artery. Flow-mediated dilation (or the dilation of blood vessels in response to an
increase in blood flow) will be measured using echo Doppler ultrasound on the surface of the
skin. The increase in blood flow is achieved by temporarily restricting blood flow to the artery.
Upon release of the occlusion cuff, blood rushes back into the artery which produces a friction
against the walls of the artery. The friction, also termed shear stress, produces dilation of the
artery which can be detected using ultrasound technology.
Guidelines for the methodological and physiological assessment of FMD have been developed
for most aspects of the procedure, however the occlusion pressure used for the assessment of
FMD varies between laboratories. The effects of these different pressures remain unknown,
making it difficult to compare studies in the literature. Theoretically any pressure above resting
systolic pressure should be sufficient to restrict blood flow however no research has been done
to look at the effects of different pressures used on the FMD response.
Additionally, the present study will examine the day-to-day variability and test-to-test repeatability
within the ultrasound measure of FMD. As well we will use near-infrared spectroscopy (as
described later) to assess microvascular deoxygenation to also reflect muscle blood flow
following cuff occlusion
Participation in this study involves visits to the research laboratory at the Canadian Centre for
Activity and Aging (Arthur and Sonia Labatt Health Science Centre, Room 313) on a maximum
of 5 different occasions (total time commitment = approximately 11 hours). Each testing session
is expected to take no longer than 2 hours to complete, however the day when 3 tests are
performed will take approximately 3 hours.
Up to 22 young adult men will be invited to participate in this study. In order to participate you
must be between 18-40 (young) years of age and healthy. You will not be able to participate in
the study if you have been previously diagnosed with any respiratory, cardiovascular, metabolic
or musculoskeletal disease; or you are currently on medication affecting cardiovascular
responses to exercise; or you are a smoker. If you are participating in another study at this time,
please inform the investigator right away to determine if it is appropriate for you to participate in
this study.
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Research Testing Protocol:
If you agree to participate in this study you will perform a series of flow-mediated dilation (FMD)
tests in the popliteal artery for five consecutive days. Two FMD tests will be performed each of
four days, with the fifth day involving three tests. Each test will be separated with a 30 minute
rest period to allow blood flow and arterial dilation to return to resting levels. The first FMD test
of each day will be done with a different occlusion pressure found in literature; 175, 200, 225,
250 or 300 mmHg. The second FMD test of each day will be performed with an occlusion
pressure of 250 mmHg, resulting in five tests performed in five consecutive days at the same
pressure – allowing us to make conclusions regarding day-to-day variation. On the day when
two FMD tests are performed with an occlusion pressure of 250mmHg, a third test at that
pressure will be performed allowing us to determine the test-to-test repeatability within the
same day. The order that the first tests will be performed in will be randomized.
Measurements: All measurement techniques have been approved previously and are used as
routine measures in our laboratory. You will lie on the ultrasound bed for 10 minutes prior to
testing to eliminate any effects of walking around or climbing stairs on resting blood flow status.
Blood pressure will be taken prior to the start of each test. FMD will be measured noninvasively using B-mode echo Doppler ultrasound. We will make continuous measures of your
popliteal artery diameters for 5 minutes following the release of a 5 minute period of lower leg
(calf) circulatory occlusion.
During each of the FMD tests, the oxygenation of your lower leg muscle will be continuously
measured non-invasively using near-infrared spectroscopy (NIRS). NIRS projects light into a
specific location of your leg muscles and measures the amount of light coming out at another
location. The amount of light that is reflected back and detected by the NIRS probe is used to
measure muscle oxygenation. A small piece of equipment (the NIRS probe) will be placed on
your lower leg approximately midway between your ankle and your knee. It will be secured with
tape, covered to prevent light from entering or leaving the area, and bound with elastic
bandage to minimize movement.
Heart rate and rhythm will be continuously monitored by electrocardiogram. One electrode will
be placed on each of the following areas: left chest, right chest, and left side under your ribs and
connected to an electrocardiograph. The electrodes use adhesive tape to secure to the skin.
There are no known risks or discomforts associated with this procedure.
Possible Risks and Discomforts:
When the occlusion cuff is inflated to restrict blood flow, there may be some associated
discomfort in the lower leg.
Participation in this study requires a time commitment that may be inconvenient for you at
some point during the study.
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Benefits of Participation:
This is a basic physiology/biochemistry study and, as such, there will be no direct benefits
received as a consequence of participating in the study. If you are interested, the rational for
conducting the research and theory and significance of each of the tests will be explained, as
will your individual results from each of the tests.
Other Pertinent Information:
You are encouraged to ask questions regarding the purpose of the study, specific measures or
outcomes of your exercise test, or overall findings and conclusions from this research study.
Confidentiality:
Records from this study are confidential and will be stored securely at the Canadian Centre for
Activity and Aging, Sonia Arthur Labatt Health Sciences Building. Your records will be identified
by a number rather than your name. The data will be available for analysis within the research
group. Published reports resulting from this study will not identify you by name. We would like
to keep and use your data in future, as of yet unknown analyses. There is a check box on the
consent form to indicate your choice. You will be able to withdraw your data at any time by
contacting the Principal Investigator, Dr. Donald H. Paterson at 519-661-1606. Representatives
of the University of Western Ontario Health Sciences Research Ethics Board may contact you
or require access to your study-related records to monitor the conduct of the research.
Voluntary Participation:
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your academic or employment
status.
You will be given a copy of this letter of information and signed consent forms. You do not waive
any legal rights by signing the consent form. If you have any questions regarding this study
please contact Dr. Donald Paterson (519-661-1606) at the Canadian Centre for Activity and
Aging, Sonia and Arthur Labatt Health Sciences Building, The University of Western Ontario,
London. If you have any question about the conduct of this study or your rights as a research
subject you may contact the Director of the Office of Research Ethics, The University of Western
Ontario, 519-661-3036 (ethics@uwo.ca).
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LETTER OF INFORMED CONSENT
How reliable are repeated measures of flow-mediated
vasodilation and what are the effects of different occlusion
pressures on the flow-mediated dilatory response?
Principal Investigator: Donald H Paterson, PhD
MSc Student: Kaitlin McLay, BSc

I have read the Letter of Information, have had the nature of this study explained to me and
I agree to participate. All questions have been answered to my satisfaction.


I consent to having my data kept for future as of yet unknown analyses.



I do not consent to having my data kept for future as of yet unknown analyses.

Participant:
____________________________
Name (please print)

___________________________
Signature

________________________
Date

Investigator (i.e. Person Responsible for Obtaining Informed Consent):
____________________________
Name (please print)

___________________________
Signature

________________________
Date
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LETTER OF INFORMATION
Effect of acute exercise training on VO2 kinetics and the relationship
to endothelial function in young and older adult men.
Principal Investigator: Donald H Paterson, PhD
PhD Student: Kaitlin McLay, MSc
Purpose of the Study:
You are being invited to participate in a research study that examines the effects of short term
exercise training on oxygen (O2) uptake and blood flow distribution. During the transition from
rest or light-intensity exercise to higher intensities, the rate of adjustment of O2 use (called “VO2
kinetics”) may depend on how rapidly certain enzymes in the muscle are activated or on how
quickly blood flow increases to supply O2 to the active muscle. In general, VO2 kinetics is slower
in older adults compared to young adults. Endurance training has been shown to speed VO 2
kinetics in as little as two training sessions in young adults; however the effect of short-term
training in older adults has not been studied. This study will compare VO 2 kinetics in older and
young adult males following short-term exercise training. Additionally, the dilation of blood
vessels in response to an increase in blood flow will be examined during and following the
exercise training to assess changes in the ability of those vessels to dilate.
Participation in this study involves visits to the laboratory at the Canadian Centre for Activity and
Aging (Arthur and Sonia Labatt Health Sciences Centre, Room 313) on a maximum of 10
different occasions, with each visit taking a maximum of 2.5 hours. Although the first two visits
are not time sensitive and can be scheduled flexibly, the other 8 need to follow a specific time
frame (see Figure 2).
A total of 24 male adults will be invited to participate in this study (12 young; 18-40 yrs and 12
older adults; 60-85 yrs). In order to participate you must be a healthy male. You will not be able
to participate in the study if you have been diagnosed previously with any respiratory,
cardiovascular, metabolic, neurological or musculoskeletal disease; or you are currently on
medication that will affect your cardiovascular response to exercise*; or you are a smoker; or you
respond to the exercise protocol in an irregular manner (i.e. chest pains, dizziness, shortness of
breath, nausea etc.) or cannot tolerate the exercise protocol. If you are participating in another
study at this time, please inform the investigator right away to determine if it is appropriate for
you to participate in this study.
* These include, but are not limited to: Angiotensin-converting enzyme inhibitors (eg. Benazepril,
Enalapril, Fosinopril); Diuretics (Hydrochlorothiazide, Metolazone, Chlorthalidone); Beta
blockers (Metoprolol, Propranolol, Bisoprolol), Calcium channel blockers (Amlodipine, Diltiazem,
Nifedipine, Verapamil hydrochloride); and Angiotensin II receptor blockers (Candesartan,
Irbesartan, Losartan). The medications listed are the pharmacological names of the drugs not
the brand names. Please note this is not a complete list and if you are unsure of the
cardiovascular response to any medications, the researchers will complete a search for the
associated effects of each medication on the cardiovascular system.
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Research Testing Protocol:
During the first visit to the laboratory, you will complete an incremental exercise test (VO2 max
test) to your limit of tolerance until you will be physically unable to continue exercising because
the intensity is either too high or too uncomfortable. The exercise will consist of leg cycling on a
cycle ergometer (a stationary bicycle) while in the upright, seated position. The test will begin
with the exercise intensity being very light (very little resistance). After several minutes the
exercise intensity will increase until you are unable to continue because of fatigue, or until you
wish to stop. This visit should last approximately one hour, and will be used as a guideline for
all subsequent bike tests.
On a separate day but prior to the commencement of training, dilation of blood vessels in the
arm and leg will be measured using echo Doppler ultrasound on the surface of the skin. The
order of the two ultrasound tests will vary for each testing session. A blood pressure cuff will be
placed below the site of the ultrasound probe (either on the calf or the forearm), inflated to restrict
blood flow and then released to monitor dilation for 5 minutes following release. Additionally,
you will perform a series of 3 moderate-steps at ~90% of your lactate threshold (as determined
by your first visit). This series of exercise steps will be performed on the cycle ergometer and
will involve transitions from very light work (ie. 20 watts; an intensity similar to slow walking) to
moderate intensity (exercise in the moderate domain could theoretically be performed indefinitely
and should not produce signs of fatigue). Repeated moderate-steps are required in order to
reduce normal biological variability associated with such testing and increase the underlying
signal-to-noise ratio which means the amount of accurate data points to the amount of errant
data points from non-uniform breathing. The lactate threshold (θL) is the exercise intensity at
which lactic acid starts to accumulate in the blood stream. The moderate-steps are performed
just below the lactate threshold because it is an intensity that can be maintained without
significant blood lactate accumulation and is therefore in the moderate-intensity exercise domain.
You will exercise while seated in the upright position on a cycle ergometer at a workload of 20
watts (W) (baseline) and after an accommodation period, the resistance will be increased to 90%
of lactate threshold (see Figure 1). Moderate step tests and ultrasound measurements will also
be completed following the second training session and 24, 48, 72 and 120 hours after the final
training session to assess acute effects of training (see Figure 2). During testing sessions, height,
weight and blood pressure measurements will be taken.
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Figure 1.

Measurements: All measurement techniques have been approved previously and are used as
routine measures in our laboratory. You will lie on the ultrasound bed for 10 minutes prior to
testing to eliminate any effects of walking around or climbing stairs on resting blood flow status.
Blood pressure will be taken prior to the start of each test. Dilation of the two blood vessels will
be measured non-invasively using B-mode echo Doppler ultrasound. We will make continuous
measures of your artery diameters for 5 minutes following the release of a 5 minute period of
blocked forearm or lower leg (calf) circulation. The order of the two ultrasound tests will vary
between visits, and an accommodation period of 30 minutes will separate the two tests to ensure
no effect of the previous test on the later.
During each of the ultrasound tests, the oxygenation of your forearm or lower leg muscle will be
continuously measured non-invasively using near-infrared spectroscopy (NIRS). NIRS projects
light into a specific location of your leg muscles and measures the amount of light coming out at
another location. The amount of light that is reflected back and detected by the NIRS probe is
used to measure muscle oxygenation. A small piece of equipment (the NIRS probe) will be
placed on your forearm or lower leg. It will be secured with tape, covered to prevent light from
entering or leaving the area, and bound with elastic bandage to minimize movement. Heart rate
and rhythm will be continuously monitored by electrocardiogram. One electrode will be placed
on each of the following areas: left chest, right chest, and left side under your ribs and connected
to an electrocardiograph. The electrodes use adhesive tape to secure to the skin. There are no
known risks or discomforts associated with this procedure.
During each of the exercise tests you will be required to wear a nose-clip (to prevent you from
breathing through your nose) and a rubber mouthpiece (similar to breathing through a snorkel or
diving mask); nose-clips and mouthpieces are disinfected before each test. This will enable us
to measure the volume of air that you breathe in and out, and measure the gas concentration in
that air.
During each of the exercise tests, the oxygenation of your leg muscle will again be measured
using NIRS. The probe will be placed on your leg approximately midway between your hip and
your knee. It will be secured with tape, covered to prevent light from entering or leaving the area,
and bound with elastic bandage to minimize movement. You might experience a bit of discomfort
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by having this equipment secured to your leg during the exercise period. However, this is a noninvasive procedure.
Arterial blood saturation will be monitored non-invasively and continuously using an oximeter
with a cuff on your ear. Heart rate and rhythm will be continuously monitored by
electrocardiogram. One electrode will be placed on each of the following areas: left chest, right
chest, and left side under your ribs and connected to an electrocardiograph. The electrodes use
adhesive tape to secure to the skin. There are no known risks or discomforts associated with
this procedure.
Training Protocol:
You will complete three exercise training sessions, separated by 1 day of rest. Each training
session will involve 30-45 minutes of continuous exercise training at 70% of your maximal oxygen
uptake (as determined by your first visit). Immediately following the first and second training
days, an ultrasound test will be performed on either the brachial or popliteal artery. The artery
that is not used on the first day will be examined immediately following the second training
session, such that only one ultrasound test is performed on each of the two training days. You
must refrain from starting any exercise training program during this study and must not be
concurrently participating in any other research studies that may interfere with the results of this
study.
Figure 2.

Possible Risks and Discomforts:
When the blood pressure cuff is inflated to restrict blood flow, there may be some associated
discomfort in the forearm or lower leg, however this sensation will disappear immediately upon
cuff release. You may experience some minor discomfort from wearing the nose-clip and rubber
mouthpiece, and by having the NIRS probes secured to your leg during the exercise period.
These sensations often become less noticeable with time during the exercise.
Any exercise carries a slight risk of a heart attack or may be uncomfortable if you are unfit or not
used to exercise. There may be some minor discomfort during the exercise training and testing.
You may experience increased awareness of breathing, muscle fatigue and soreness, increased
138

sweating, or a general feeling of fatigue or nausea, none of which are unexpected consequences
of exercise.
All testing procedures will only be conducted when a lab technician or research assistant that is
certified in CPR is present. In the case of an emergency, 911 will be called using the telephone
located in the testing laboratory. An automatic external defibrillator is also available within the
testing building. If a heavy pressure sensation or pain develops in your chest or down your left
arm it is important that you discontinue the exercise immediately and report these sensations to
the exercise supervisor, or seek medical attention if you have left the exercise area.
Participation in this study requires a time commitment that may be inconvenient for you at some
point during the study.
Benefits of Participation:
This is a basic physiology/biochemistry study and, as such, there will be no direct benefits
received as a consequence of participating in the study. If you are interested, the rationale for
conducting the research and theory and significance of each of the tests will be explained, as
will your individual results from each of the tests.
Other Pertinent Information:
You are encouraged to ask questions regarding the purpose of the study, specific measures or
outcomes of your exercise test, or overall findings and conclusions from this research study.
Confidentiality:
Records from this study are confidential and will be stored securely at the Canadian Centre for
Activity and Aging, Sonia Arthur Labatt Health Sciences Building. Your records will
be identified by a number rather than your name. The data will be available for analysis within
the research group. Published reports resulting from this study will not identify you by name.
We would like to keep and use your data in future, as of yet unknown analyses. There is a
check box on the consent form to indicate your choice. If you consent, following the removal of
all personal identifiers (only linked to a research number), data are stored indefinitely as
information may be used later in other research comparisons of aging or included as part of a
database on aging held in the Canadian Centre for Activity and Aging. All written and
password-protected computer files are filed under a research number and are secured at the
Canadian Centre for Activity and Aging Laboratory in a locked filing cabinet accessible only to
investigators and research assistants. You will be able to withdraw your data at any time by
contacting the Principal Investigator, Dr. Donald H. Paterson at 519-661-606. Representatives
of the University of Western Ontario Health Sciences Research Ethics Board may contact you
or require access to your study-related records to monitor the conduct of the research.
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Voluntary Participation:
Participation in this study is voluntary and there is no compensation for participating in the study.
You may refuse to participate, refuse to answer any questions or withdraw from the study at any
time with no effect on your academic or employment status.
You will be given a copy of this letter of information and signed consent forms. You do not waive
any legal rights by signing the consent form. If you have any questions regarding this study
please contact Dr. Donald Paterson (519-661-1606) at the Canadian Centre for Activity and
Aging, Sonia and Arthur Labatt Health Sciences Building, The University of Western Ontario,
London. If you have any question about the conduct of this study or your rights as a research
subject you may contact the Director of the Office of Research Ethics, The University of Western
Ontario, 519-661-3036 (ethics@uwo.ca).
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LETTER OF INFORMED CONSENT
Effect of acute exercise training on VO2 kinetics and the relationship
to endothelial function in young and older adult men.
Principal Investigator: Donald H Paterson, PhD
PhD Student: Kaitlin McLay, MSc
I have read the Letter of Information, have had the nature of this study explained to me and I
agree to participate. All questions have been answered to my satisfaction.


I consent to having my data kept for future as of yet unknown analyses.



I do not consent to having my data kept for future as of yet unknown analyses.

Participant:
____________________________
Name (please print)

___________________________
Signature

________________________
Date

Investigator (i.e. Person Responsible for Obtaining Informed Consent):
____________________________
Name (please print)

___________________________
Signature

________________________
Date
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LETTER OF INFORMED CONSENT
Vascular Occlusion Duration and the NIRS-Derived
Reperfusion Rate of Tissue Oxygen Saturation in
Healthy Subjects
Principal investigator: Juan M. Murias, PhD
This consent form is only part of the process of informed consent. It should give you the
basic idea of what the research is about and what your participation will involve. If you
would like more detail about something mentioned here, or information not included here,
please ask. Take the time to read this carefully and to understand any accompanying
information. You will receive a copy of this form.
BACKGROUND
You are being invited to participate in a study that examines the blood flow response to
different occlusion periods. Previously near-infrared spectroscopy (NIRS) has been widely
used to determine changes in oxygen saturation during exercise. More recently, NIRS has
been used to measure tissue oxygen saturation in response to a brief period of blood flow
restriction, termed a vascular occlusion test (VOT). The VOT has been used in healthy
and clinical populations to determine the response of blood flow and may be useful
identifying the responsiveness of small vessels.
WHAT IS THE PURPOSE OF THE STUDY?
The goal of this study is to compare 6 different blood flow restriction durations (30 seconds,
1, 2, 3, 5 and 10 minutes) in healthy young individuals.
WHAT WOULD I HAVE TO DO?
To be part of the study, the following admission criteria will be considered: you will have
to be healthy, non-smoker, non-obese, normotensive, with no peripheral vascular occlusive
disease, not taking medications that are known to affect cardiovascular or hemodynamic
responses to exercise (e.g., β-blockers, blood pressure medication, anti-inflammatories,
anti-coagulants, etc.).
Once accepted in to the study, you will be required to come into the laboratory for two
testing sessions:
1) During this 3.5-hour testing session, you will complete a series of blood flow restriction
tests for 6 different durations (30 seconds, 1, 2, 3, 5 and 10 minutes). Blood flow restriction
will be achieved by inflating a blood pressure cuff to 250 mmHg, a pressure above your
resting systolic blood pressure to prevent flow below the cuff. The order of the tests will
be randomized and each test will be separated by a 30 minute rest period to allow blood
flow following cuff release to return to baseline levels.
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2) During this visit you will complete an incremental exercise test (VO2max test) to your
limit of tolerance until you will be physically unable to continue exercising because the
intensity is either too high or too uncomfortable. The exercise will consist of cycling on a
cycle ergometer (a stationary bicycle) while in the upright, seated position. The test will
begin with the exercise intensity being very light (very little resistance). After several
minutes the exercise intensity will gradually increase until you are unable to continue
because of fatigue, or until you wish to stop. This visit should last approximately 45
minutes.
Measurements: All measurement techniques are used as routine measures in our
laboratory. During each of the 6 tests described in the first point above, the oxygenation of
the tibialis anterior and gastrocnemius muscles will be continuously measured noninvasively using near-infrared spectroscopy (NIRS). NIRS projects light into a specific
location of your leg muscles and measures the amount of light coming out at another
location. The amount of light that is reflected back and detected by the NIRS probe is used
to measure muscle oxygenation. A small piece of equipment (the NIRS probe) will be
placed on your lower leg approximately midway between your ankle and your knee. It will
be secured with tape, covered to prevent light from entering or leaving the area, and bound
with elastic bandage to minimize movement. During the test described in the second point
above, you will be required to wear a mask connected to a volume turbine so that gas
concentration in the air and ventilatory rates can be measured. This will enable us to
measure the volume of air that you breathe in and out, and measure the gas concentration
in that air. Masks and turbines are disinfected before each test. Additionally, heart rate will
be continuously monitored by a heart rate monitor. There are no known risks associated
with any of these technical procedures.
WHAT ARE THE RISKS?
There might be some minor pain and discomfort experienced during the blood flow
restriction periods of testing. These sensations will immediately disappear once the cuff is
released.
Blocking blood flow for any period of time may increase your risk for developing a blood
clot, due to increased blood pooling in the extremities. In extremely rare cases, this may
lead to the development of a severe blood clot, known as a deep-vein thrombosis (DVT)
requiring immediate medical attention, and potential further complications. If you have any
pre-existing medical conditions, it is essential that you inform the researchers prior to
testing, as your participation may carry additional risks.
Note that no studies known to date have shown NIRS to have harmful effects on health.
However, research on rats has suggested that prolonged visual exposure to near-infrared
light can cause eye damage.
Any exercise carries a slight risk or may be uncomfortable if you are unfit or not used to
doing exercise. The risk of a cardiac event (heart attack, dysrhythmias, etc.) in a mixed
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subject population (healthy low risk and unhealthy high risk patients together) is
approximately 6:10,000; however, the risk decreases in a previously healthy (i.e. young
moderately active) population (adapted from ACSM’s Guidelines for Exercise Testing and
Prescription). There might be some minor discomfort during the exercise testing. You may
experience increased awareness of breathing, muscle pain and/or fatigue, increased
sweating, or a general feeling of fatigue or nausea, all of which are not unexpected
consequences of exercise. You may experience some minor discomfort from wearing the
breathing mask necessary for VO2 measurements
Additionally, know that participation in this study requires a significant time commitment
that may be inconvenient for you at some point in the study.
All testing procedures will only be conducted when a lab technician or research assistant
that is certified in CPR is present. In the case of an emergency, 911 will be called using a
telephone available in the testing laboratory. An automatic external defibrillator is also
available within the testing building.
WILL I BENEFIT IF I TAKE PART?
This is a basic physiology/biochemistry study and, as such, there will be no direct benefits
received as a consequence of participating in the study. If you are interested, the rationale
for conducting the research and theory and significance of each of the tests will be
explained, as will your individual results from each of the tests. You will also have the
opportunity to learn about and better understand your physiological responses to an
exercise situation. You are encouraged to ask questions regarding the purpose of the study,
specific measures or outcomes of your exercise test, or overall findings and conclusions
from this research study.
DO I HAVE TO PARTICIPATE?
Your participation in this research project is entirely voluntary. You can withdraw anytime
by sending an email to jmmurias@ucalgary.ca or by expressing this desire verbally to the
investigators.
You might be withdrawn from the study for the following reasons:




Changes in your status so that you do not fit within the admission criteria for this study.
You cannot complete all testing sessions within the proposed period of the study.
You are not able to comply with the instructions prior to each testing session.

If new information becomes available that might affect your willingness to participate in
the study, you will be informed as soon as possible.
WHAT ELSE DOES MY PARTICIPATION INVOLVE?
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Your participation in this study does not involve anything else beyond what is specified on
this informed consent.
WILL I BE PAID FOR PARTICIPATING, OR DO I HAVE TO PAY FOR
ANYTHING?
You will not be paid for your participation in this research project.
WILL MY RECORDS BE KEPT PRIVATE?
Information obtained during this research project is confidential. Nobody except the
researchers will have access to your personal information. Your records are listed
according to an identification number rather than by your name. Published reports resulting
from this study will not identify you by name. Thus, your right to privacy will be retained.
If you require it, you will be given a summary of your results and the average results for
all participants in this study.
IF I SUFFER A RESEARCH-RELATED INJURY, WILL I BE COMPENSATED?
In the event that you suffer injury as a result of participating in this research, no
compensation will be provided to you by the University of Calgary, or the Researchers.
You still have your legal rights. Nothing said in this consent form alters your right to seek
damages.
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SIGNATURES
Your signature on this form indicates that you have understood to your satisfaction the
information regarding your participation in the research project and agree to participate as
a participant. In no way does this waive your legal rights nor release the investigators or
involved institutions from their legal and professional responsibilities. You are free to
withdraw from the study at any time without consequences. If you have further questions
concerning matters related to this research, please contact:
Dr. Juan M. Murias (403) 220-7955 or jmmurias@ucalgary.ca
If you have any questions concerning your rights as a possible participant in this research,
please contact the Chair, Conjoint Health Research Ethics Board, University of Calgary
at 403-220-7990.

Participants Name

Signature and Data

Investigator’s name

Signature and Date

Witness’ name

Signature and Date

The University of Calgary Conjoint Health Research Ethics Board has approved this
research study.
A signed copy of this consent form has been given to you to keep for your records and
reference.
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PERMISSION TO REPRODUCE PREVIOUSLY PUBLISHED MATERIALS

Chapter II:
Prior permission from Experimental Physiology is not required if the purpose of the
reproduction is for inclusion in a thesis dissertation.
Chapter III:
Prior permission from Physiological Reports is not required if the purpose of the
reproduction is for inclusion in a thesis dissertation.
Chapter V:
Prior permission from Experimental Physiology is not required if the purpose of the
reproduction is for inclusion in a thesis dissertation.

147

CURRICULUM VITAE

Kaitlin M. McLay
School of Kinesiology, Faculty of Health Sciences
Canadian Centre for Activity and Aging
The University of Western Ontario
London, Ontario, Canada

Education
2012 - 2016

Doctor of Philosophy (Ph.D.), Integrative Physiology of Exercise, The
University of Western Ontario, London, Ontario

2010 - 2012

Master of Science (M.Sc.), The University of Western Ontario, London,
Ontario

2006 - 2010

Honors Bachelor of Science (B.Sc.H.), Biological Sciences, University
of Guelph, Guelph, Ontario

Research
Peer-Reviewed Original Research Publications (4)
1. McLay, K.M., Fontana, F.Y., Nederveen, J.P., Guida, F.F, Paterson, D.H., Pogliaghi,
S. & Murias, J.M. (2016) Vascular responsiveness determined by near-infrared
spectroscopy measures of oxygen saturation. Experimental Physiology. Jan
1;101(1):34-40.
2. McLay, K.M., Nederveen, J.P., Pogliaghi, S., Paterson, D.H. & Murias, J.M. (2016)
Repeatability of vascular responsiveness measures derived from near-infrared
spectroscopy. Physiological Reports. Mar 4 (9):e12772
3. McLay, K.M., Gilbertson, J.E., Pogliaghi, S., Paterson, D.H. & Murias, J.M. (2016)
Vascular responsiveness measured by tissue oxygen saturation reperfusion slope is
sensitive to different occlusion durations in healthy trained and untrained young men.
Experimental Physiology, In press.
4. Maturana Mattioni, F., Keir, D.A., McLay, K.M. & Murias, J.M. (2016) Can measures
of critical power precisely estimate the maximal metabolic steady state? Applied
Physiology, Nutrition, and Metabolism, In press.

148

Refereed Abstracts (12)
1. McLay, K.M., Mattioni Maturana, F. & Murias J.M. (2016). Experienced cyclists
predict the highest sustainable intensity of exercise more effectively than critical power
testing. Medicine & Science in Sports & Exercise
2. Mattioni Maturana, F., McLay, K.M. & Murias J.M. (2016). Can measures of critical
power precisely estimate the maximal metabolic steady state? Medicine & Science in
Sports & Exercise
3. McLay, K.M., Gilbertson, J.E., Paterson, D.H. & Murias, J.M. (2016). Vascular
responsiveness measured by tissue oxygen saturation reperfusion slope is sensitive to
different occlusion durations in healthy trained and untrained young men. Okanagan
Cardiovascular and Respiratory Symposium.
4. McLay, K.M., Nederveen, J.P., Pogliaghi, S., Paterson, D.H. & Murias, J.M. (2016)
Repeatability of vascular responsiveness measures derived from near-infrared
spectroscopy. Okanagan Cardiovascular and Respiratory Symposium.
5. McLay, K.M., Paterson, D.H. & Murias, J.M. (2015). Effects of short-term exercise
training and detraining on V̇O2 kinetics in young and older adults. Applied Physiology,
Nutrition, & Metabolism Suppl.
6. McLay, K.M., Fontana F.Y., Nederveen, J.P., Guida, F.F, Paterson, D.H., Pogliaghi,
S. & Murias, J.M. (2015). Vascular responsiveness determined by near-infrared
spectroscopy measures of oxygen saturation. Applied Physiology, Nutrition, &
Metabolism Suppl.
7. McLay, K.M., Fontana F.Y., Pogliaghi, S., Paterson, D.H. & Murias, J.M. (2014). Can
NIRS derived measures of oxygen saturation differentiate vascular responsiveness in
young and older adults? Applied Physiology, Nutrition, & Metabolism Suppl.
8. McLay, K.M., Murias, J.M., Nederveen, J.P, & Paterson, D.H. (2013). Analysis of
flow-mediated dilation in the popliteal artery using manual detection compared with
edge-tracking software. Applied Physiology, Nutrition, & Metabolism Suppl.
9. McLay, K.M., Murias, J.M., Nederveen, J.P. & Paterson, D.H. (2013). Day-to-day
reliability of flow-mediated dilation measures in the popliteal artery. Medicine &
Science in Sports & Exercise:
10. McLay, K.M., Murias, J.M., Nederveen, J.P. & Paterson, D.H. (2012). Test-to-test
repeatability of FMD measures in healthy young adult males. Applied Physiology,
Nutrition, & Metabolism 37:S24.

149

11. McLay, K.M., Dogra, S.K. & Paterson, D.H. (2012) Responsiveness of the Popliteal
Artery in Older Trained and Untrained Women. Medicine & Science in Sports &
Exercise: Suppl.
12. Spencer, M.D., Murias, J.M.; Gravelle, B.M.R., McLay, K.M., Kowalchuk, J.M. &
Paterson, D.H. (2011) Does Improved Local O2 Distribution Explain Faster VO2
Kinetics During Smaller Compared To Larger Moderate-intensity Transitions?
Medicine & Science in Sports & Exercise: Suppl. Vol 43 (5):387.

Grants and Awards
Grants
2015 - 2016

Ontario Graduate Scholarship (OGS), Ministry of Training, Colleges
and Universities – funded for 3 terms

2012 - 2016

Western Graduate Research Scholarship, University of Western
Ontario Institutional Scholarship – 2012-16 academic year(s)

2011 – 2012

Queen Elizabeth II Graduate Scholarship in Science and Technology
(QEIIST), Ministry of Training, Colleges and Universities – funded for 3
terms

2010 - 2012

Western Graduate Research Scholarship, University of Western
Ontario Institutional Scholarship – 2010-12 academic year(s)

Travel Grants and Other Awards
2016

Faculty of Health Sciences Graduate Student Conference Travel
Award, The University of Western Ontario

2015

Faculty of Health Sciences Graduate Student Conference Travel
Award, The University of Western Ontario

2015

School of Kinesiology Travel Award, The University of Western
Ontario

2014

Faculty of Health Sciences Graduate Student Conference Travel
Award, The University of Western Ontario

2014

School of Kinesiology Travel Award, The University of Western
Ontario

150

2013

Faculty of Health Sciences Graduate Student Conference Travel
Award, The University of Western Ontario

2013

School of Kinesiology Travel Award, The University of Western
Ontario

2013

Graduate Thesis Research Award, The University of Western Ontario

2012

School of Kinesiology Travel Award, The University of Western
Ontario

2012

Faculty of Health Sciences Graduate Student Conference Travel
Award, The University of Western Ontario

151

